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Adviser: Dr. Eileen Gigliotti 
Purpose:  People living with MS need to employ both problem and emotion-focused coping 
strategies to maintain optimal health. Specifically, with one’s Perceived Health Status as an 
indicator of optimal health, treatment adherence and religious coping are indicators of problem 
and emotion-focused coping, respectively. This study aimed to examine the relations between 
Perceived Health Status, the dependent variable, and the independent variables Adherence to 
DMT and Religious Coping. Based on the Neuman Systems Model (Neuman & Fawcett, 2011) 
and Pargament's Theory of Religious Coping (1997), it was proposed that Adherence to DMT 
and Religious Coping are respectively one's physiological and spiritual lines of resistance that 
would affect reconstitution to the Normal Lines of Defense, Perceived Health Status.   
Method:  This was a cross-sectional randomized sample (N = 266), response rate 46%, of adults 
from a national MS registry (NARCOMS) who completed the RAND Short Form-36 (SF-36) 
questionnaire, the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) Barriers 
Subscale, the Brief Religious Cope (Brief RCOPE) Questionnaire, and demographic data to 





effect size of .065, determined statistical significance.  Data were analyzed using regression, 
correlations, ANOVA, chi-square, and t-tests. 
Findings: Together,  Adherence to DMT nor Religious Coping (R2 = .02, p = .159) did not 
influence Perceived Health Status in this study. However, ancillary analyses revealed the best 
predictor of Perceived Health Status was employment status (β = 6.29, p < .001) with significant 
variations noted among the employment groups (F (4,250) = 19.07, p < .001). People who report 
being unable to work had significantly lower mean Perceived Health (M = 40.09, SD = 14.79) 
scores than all other employment groups.   
Conclusions:  There is some support for the conceptual and theoretical link between Neuman's 
Systems Model (Neuman & Fawcett, 2011) and Pargament's Theory of Religious Coping (1997). 
The spiritual variable worked to weakly influence Reconstitution via Negative Religious Coping. 
Participants who used less Negative Religious Coping reported better Mental Health. Future 
studies should focus on employment status and its role as a stressor influencing the Lines of 
Resistance. Research with people with MS should include measuring appraisal methods they use 
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The Research Objective 
Perception of one’s current health status, especially in patients with chronic disease, 
indicates how well one is coping with the disease and its effects (McCabe & McKern, 2002).  
Thus, one’s Perceived Health Status is the outcome of coping. If coping is effective, Perceived 
Health Status should be high, and ineffective coping should result in low Perceived Health 
Status.  However, because health perception is a continual process of reappraisal (Phillips et al., 
2009), then the reverse must also hold: coping can be seen as the outcome of health perception.  
That is, one’s Perceived Health Status can be the stimulus that evokes coping behaviors. 
Therefore, knowledge of health perception and coping mechanisms is vital to health care 
professionals as they seek to assist patients in this coping process.  
This knowledge is especially crucial to Multiple Sclerosis (MS) health care providers 
because MS, a neurological disease that affects over 1million people in the United States 
(Walton et al., 2020), is characterized by onset in early adulthood and an unpredictable but 
progressive decline in all body systems.  People with MS face a lifetime of coping with the limits 
and consequences of progressive neurological disease and rely on treatments that offer no cure. 
(Bonsaksen, Lerdal, & Fagermoen, 2015; Ghafari, Khoshknab, Nourozi, & Mohammadi, 2015).  
Coping with MS requires a continuous reappraisal of the disease's effects and work to solve or 
manage perceived problems to return to optimum health. Patients use problem and emotion-
focused coping strategies to preserve optimal health and continuously redefine personal goals 
(Büssing, Osterman, Neugebauer, & Heusser, 2010).   
Problem-focused coping concerns the physiological management of MS and is centered 





(DMT) can reduce clinical symptoms, slow disability progression, and decrease central nervous 
system lesions (Steinberg, Faris, Chang, Chan, & Tankersley, 2010).  Clinical outcomes and cost 
to the individual and society are directly related to DMT adherence (Lizán et al., 2014).  
However, adherence is not easy and requires emotion-focused coping. Emotion-focused  
coping involves ongoing cognitive reappraisal to self-reflect and make choices to adapt  
to stressors (Baldacchino, Borg, Muscat, & Sturgeon, 2012;  Folkman & Moskowitz, 2000).  
Though there are many emotion-focused coping strategies, Rosmarin, Wachholtz, and Ai (2011) 
note that religion is commonly used and may positively impact health indices, especially  
in people with chronic disease. When faced with stress, people often turn to religion to  
restore order to their lives, and religious coping plays a crucial role throughout the  
illness (Exline et al., 2014).   
People living with MS need to employ both problem and emotion-focused coping 
strategies to maintain optimal health. Specifically, with one’s Perceived Health Status as an 
indicator of optimal health, treatment adherence and religious coping are indicators of problem 
and emotion-focused coping, respectively. This study will investigate the relations between 
Perceived Health Status, DMT Treatment Adherence, and Religious Coping in people with MS. 
The Problem 
 What are the relations among Perceived Health Status, Adherence to DMT, and Religious 
Coping in adults with MS? 
Definitions 
Perceived Health Status 
Perceived Health Status is conceptually defined as health concepts relevant to the patient 





Perceived Health Status is operationally defined as scores on the RAND SF-36 physical and 
mental health components (Ware & Sherbourne, 1992).   
Adherence DMT   
Adherence to DMT is conceptually defined as the extent to which a patient acts in 
accordance with the prescribed interval and dose of DMT within the past four weeks (Cramer et 
al., 2008).  Adherence to DMT is operationally defined as Missed Dose Ratio (MDR) scores 
from the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) Barriers subscale 
(Wicks et al., 2011).  
Religious Coping 
Religious Coping is conceptually defined as efforts by people to understand and come to 
terms with personal stressors in ways related to the sacred (Pargament, 1997).  Religious Coping 
is operationally defined as scores on the Brief-RCOPE (Pargament, Feuille, & Burdzy, 2011) 
which measures Positive and Negative Religious Coping.  People using Positive Religious 
Coping view stressors as a chance to transform for the better and have a collaborative 
relationship with the sacred. People using Negative Religious Coping are self-directing or view 
stressors as punishment from the sacred and may have spiritual and religious struggles.  
Delimitations  
The proposed sample were males and females, 18 years of age and older in the United 
States (US) with a clinically definite MS diagnosis.  All were currently taking a US Food and 
Drug Administration (FDA) approved DMT prescribed by a health care provider and will have 
been taking this DMT for at least six months at study enrollment.  The stipulation that DMT use 
must be current and have lasted at least six months is due to Coyle et al. (2014) and Devonshire 





Participants were recruited from a US national database of over 38,000 adults with MS to 
provide a randomized sample and strengthen the study's external validity.  Thus, participation 
was limited to only those on an FDA-approved DMT.  
Differences in adherence to DMT were similar regardless of the type of MS or treatment 
duration (Devonshire et al., 2011a; Tan et al., 2011). Therefore, all patients on any prescribed 
DMT were eligible to participate. Regarding the effects of marital status on the study variables, 
there are conflicting findings. Ren (1997) found that marital or cohabitating status influences 
Perceived Health Status. However, McCabe and McKern (2002) found no statistically significant 
relation between relationship status and perceived health. The participants' marital status data 
were analyzed to determine if there were statistically significant differences between the groups 
on study variables.   
Research on Religious Coping included participants of all religious denominations: 
Christianity, Judaism, Muslims, other religions, and people who identify as atheists, agnostics, or 
without a designated religious faith (Pargament, 1997; Pargament, Koenig, & Perez, 2000; 
Pedersen, Pedersen, Pargament, & Zachariae, 2013; Trevino et al., 2010).  The study included 
people with MS of all religious faiths/lack of faith. Adults who are not capable of self-
administration were excluded from the study because, in an extensive observational study, 32% 
of participants were not adherent due to not having someone administer the DMT (Turner, 
Kivlahan, Sloan, & Haselkorn, 2007).  Also excluded are those who are non-English speaking 
because all study instruments are in English.  
Theoretical Rationale 
 The Neuman System Model (NSM) (Neuman & Fawcett, 2011) and the Pargament 





to DMT come together to influence Perceived Health Status in adults with MS.  Both 
frameworks describe possible adaptational outcomes when individuals try to cope and adjust to 
situational demands that affect health and well-being. The NSM and Pargament’s Theory of 
Religious Coping incorporate stress and coping elements from the seminal work of Lazarus and 
Folkman (1984).   
According to Lazarus and Folkman (1984), the coping process is continually changing to 
enable people to manage environmental stressors that are cognitively appraised as exceeding 
personal resources. They describe two forms of coping: problem-focused and emotion-focused.  
Folkman (2010) posits that problem-focused coping involves planful problem solving, and 
emotion-focused coping involves regulating negative emotions.  
In the NSM (Neuman & Fawcett, 2011), environmental stressors lead to system 
instability, which sets in motion attempts to return to well-being by activating coping 
mechanisms.  The NSM views the client as an open and multidimensional system. The 
environment is external and internal and depicted by a series of concentric circles called the 
flexible line of defense, normal line of defense, and lines of resistance that protect the client’s 
basic structure or central core from environmental stressors (see Appendix A). To understand the 
model wholistically, one must consider the individual’s five-person variables: physiological, 
psychological, sociocultural, developmental, and spiritual, which are inherent in all lines of 
defense and resistance and therefore affect the degree of protection against stressors.  
Stressors can cause system instability disrupting the normal line of defense, which is the 
person’s typical state of wellness. The lines of resistance are then activated to protect the core 
from instability and help the person return to a state of wellness. If the lines of resistance are not 





Stressors that strain the client system can affect any or all of the five-person variables in the lines 
of resistance. 
 When stressors invade the normal line of defense or normal state of wellness, the 
individual uses the lines of resistance to cope and optimally adjust to the new circumstances.  
Neuman refers to this process as Reconstitution, a dynamic state where the client system    
adjusts to the new normal (Gehrling, 2011). The reconstitution process helps rebuild the    
normal line of defense and regain a, sometimes redefined, state of wellness  
(Gehrling & Memmott, 2008; Gehrling, 2011). Reconstitution is an ongoing process that  
requires continuous psychological processes to manage the change (Gigliotti, 2012). 
Pargament’s Theory of Religious Coping (1997) provides greater specificity to one aspect 
of the reconstitution process described by Neuman (Neuman and Fawcett, 2011) and       
Gehrling (2011). Specifically, Pargament (1997) describes coping behaviors related to Neuman’s 
spiritual variable in the lines of resistance. According to Pargament (1997), coping behaviors are 
dynamic processes between people’s life situations and spiritual and religious dimensions.  
Individuals, therefore, take an active role in responding to and acting on life stressors by 
exhibiting coping behaviors in ways related to the sacred.  
The Religious Coping methods involve active, passive, and interactive methods and are 
used explicitly to cope with stressful events that threaten a person’s fundamental beliefs 
(Folkman & Moskowitz, 2000; Pargament, 1997). Religious Coping can be both positive and 
negative (Pargament, Smith, Koenig, & Perez, 1998) and includes appraisal and reappraisal of 
God’s power.  Positive Religious Coping is associated with better Perceived Health Status  
(Hebert, Zdaniuk, Schulz, & Scheier, 2009; Lee, Nezu, & Nezu, 2014; Pargament et al., 1998). 





and hopelessness, possibly due to the belief that illness is God’s punishment for disobedience 
(Cummings & Pargament, 2010; Park & Dornelas, 2012).   
Positive Religious Coping involves a collaborative give and take relationship with the 
higher power. Collaborative people have high self-esteem and exhibited the best sense of 
personal control over what happens in their lives. Alternatively, Negative Religious Coping 
involves self-directing and deferring behaviors. Self-directed people rely only on themselves to 
cope with stressors with minimal reliance on a higher power for help to cope. Deferring people 
typically have lower self-esteem, lower personal control, and rely on chance to explain how 
things happen in their lives (Pargament, 2013). 
Both theorists' propositions and assumptions can be used to describe the relations among 
Perceived Health Status, Religious Coping, and Adherence to DMT in adults with MS.  The MS 
diagnosis constitutes a stressor that invades the normal defense line, thereby disrupting the 
steady-state of dynamic equilibrium.  To return to a steady state of optimal functioning, defined 
as high Perceived Health Status, a person with MS must cope and adjust to changes brought on 
by a chronic illness. The person’s lines of resistance help the person with choices and 
possibilities to manage the stress of MS. The physiological and spiritual lines of resistance are 
activated to cope with the stressor. In a patient with MS, the normal line of defense is a 
participant’s Perceived Health Status, DMT’s and Religious Coping are the physiological and 
spiritual variables in the lines of resistance. These lines of resistance help a person to adapt to the 
changes and find meaning in the encounter by reorienting and revising definitions of health. 
Good Adherence to DMT’s and positive Religious Coping would result in high Perceived Health 
Status: Reconstitution. If the person cannot use these coping mechanisms, then Reconstitution 





In summary, positive perceived health results when people with MS can appraise MS's 
challenges and effectively use DMT and religious coping to reconstitute to a new normal line of 
defense. It is proposed that Adherence to DMT and Religious Coping work together to predict 
Perceived Health Status in adults with MS.  
Research Question 
Considered together, does Adherence to DMT and Religious Coping explain a 
statistically significant portion of the explained variance in Perceived Health Status in patients 
diagnosed with MS?  
Need For The Study 
People with MS must cope with the devastating effects of a chronic illness that leads to 
varying levels of disability (Chen et al., 2011).  This disability can adversely affect their 
perceived health.  Adherence to DMT, a problem-focused means of coping, is crucial to 
mitigating the disease's effects. McCabe and McKern (2002) note that problem and emotion-
focused coping strategies predict adjustment to MS. Also, Dehghani, Keshavarzi, Jahromi, 
Shahsavari isfahani, and Keshavarzi (2018) note that behavioral and cognitive coping strategies 
influence adjustment and provide an avenue to improve perceived health in people with MS.  To 
date, little attention has been given to the role of religious coping as an emotion-focused coping 
strategy in MS.  
Clark, Drain, and Malone (2003), commissioned by the Joint Commission, a US 
healthcare accrediting organization, reviewed satisfaction data from US hospitals and found 
strong relationships between patient satisfaction and staff’s involvement in the patient's 
emotional and spiritual needs.  Therefore, the Joint Commission requires a spiritual assessment 





coping with illness (Joint Commission, n.d.). This study investigated the importance of Religious 
Coping when used in conjunction with Adherence to DMT to predict Perceived Health Status in 
people with MS. 
Theoretically, this study can add information about the NSM concept of Reconstitution.  
Gehrling (2011) noted that the investigations of the NSM concept of Reconstitution are lacking.  
Also, though Gigliotti (2012) called for a focus on the reconstitution effects of the lines of 
resistance, to date, no reported studies have examined these effects empirically.  Finally, this 
study's results could better inform health care providers about when and how to intervene with 
people with MS who are at risk for adverse outcomes. Healthcare professionals may take more 
seriously those who draw upon religious coping methods to cope with their illness and initiate a 
timely referral and psycho-spiritual interventions to support positive religious coping, improving 












Review of the Literature 
 This chapter includes a literature review of the study variables, Perceived Health Status,  
Adherence to DMT and Religious Coping. Perceived Health Status is presented first as it 
pertains to stress and appraisal in people with MS. Adherence to DMT is then discussed, 
including factors influencing Adherence to DMT and Adherence to DMT in people with MS. 
Finally, Religious Coping is presented, including a discussion of the relations between stress, 
coping, and health outcomes. 
Perceived Health Status 
MS is the most common neurological disease that affects young and middle-aged adults 
contributing to physical, emotional, and cognitive problems that may significantly decrease a 
person’s overall quality of life and, therefore, their Perceived Health Status (Benedict et al., 
2005).  Perceived Health Status is affected because MS affects both physical disability (Thong et 
al., 2009) and physical functioning (Pugliatti et al., 2008) and psychosocial factors such as 
anxiety (Pontone et al., 2011), social support, depression (Krokavcova et al., 2008) and, stress 
(Senn et al., 2014).  Within the NSM, MS is an intrapersonal stressor that taxes the system 
resulting in disruption to the normal lines of defense, producing physical and psychological 
coping responses to return to a stable state (Gehrling & Memmott, 2008).   
Stressors can also be classified as the interpersonal and extrapersonal dimensions of an 
individual, and the reactions to the stressors are influenced by cognitive appraisal and coping 
(Lazarus, 1999). The NSM (Neuman, & Fawcett, 2011) posits that the outcome of appraisal and 
coping is Reconstitution. Reconstitution represents a return to and maintenance of system 





wellness – a new normal.  So knowing how people appraise, cope, and adhere to treatment 
recommendations should be an essential MS management objective (Benito-León, Morales, & 
Rivera‐Navarro, 2002; Heiskanen, Meriläinen, & Pietilä, 2007). The use of strategies that help 
people cope and adjust to MS may allow Reconstitution and improve Perceived Health Status in 
people with MS.  
Perceived Health Status Defined  
Perceived Health Status is the subjective experience of illness on an individual’s physical 
and psychological well-being and is predictive of morbidity and mortality (Charmaz, 1995; Xiao 
& Barber, 2008).  Lazarus and Folkman (1984) postulate that cognitive appraisal's subjective 
process may differ with context, over time and inter and intra-personally helping patients cope 
with stressors relevant to health status.  
Therefore, how an individual appraises and views the effects of disease stressors on their 
lives informs decision making and influences the degree of acceptance and adjustment to 
physical changes. Acceptance and adjustment to disease stressors may result in planful problem-
solving and positive reappraisal of the problem to help patients manage and work towards a 
perceived favorable outcome. Alternatively, such acceptance and adjustment may be negatively 
influenced by depression and emotional distress leading to inaction and unfavorable outcomes.  
Ultimately, the person’s perspective and experiences can help healthcare providers identify 
patient goals, priorities, and concerns for healthcare resulting in a collaborative care approach to 
disease management (Ahmed et al., 2012).  
Perceived Health Status In MS   
Rapkin and Schwartz (2016) suggest that, in patients with MS, cognitive appraisal 





arrive at Perceived Health Status. In their mixed-method longitudinal analysis of secondary 
patient-reported outcomes obtained from the North American Research Committee on Multiple 
Sclerosis (NARCOMS), the RAND SF-12 (Hays et al., 1995) was used to measure the physical 
(PCS) and mental (MCS) health components of Perceived Health Status.  The RAND SF-12 
Health Survey has just 12 questions and is a shorter version of the SF-36 (Ware & Sherbourne, 
1992) Health Survey used in the present study. Cognitive appraisal processes were assessed 
using the QOL appraisal profile (Morganstern et al., 2011). The sample (N = 859) had a mean 
age of 55 years, and 74% of the participants were female, which is in line with MS gender 
prevalence distribution (Chao et al., 2011).  
Rapkin and Schwartz (2016) identified four cognitive appraisal processes that people use 
to rate their Perceived Health Status. These key appraisal processes describe the person’s 
personal goals or frame of reference, how the individual recalls previous experiences to make 
decisions, the individual’s standard of comparisons used to appraise experiences, and a person’s 
subjective algorithm used to arrive at Perceived Health Status (Rapkin & Schwartz, 2004).        
In contrast, a healthcare provider’s perception of an individual’s health status is based only  
on clinical signs and may not be congruent with the person’s own Perceived Health Status.     
The authors suggest that the four appraisal processes, personal goals/frame of reference, 
experience recall, standards of comparison, and the personal combinatory algorithm may  
allow an individual to rate their Perceived Health Status the same, lower or higher than the 
healthcare provider ratings.  
They found that patients with self-rated PCS higher than the provider’s rating appraised 
personal goals, recalled recent experiences, and compared themselves to a time before MS. 





the difficulties they may face with MS and manage those difficulties. These patients also used 
sampling experiences that emphasized the positives, sought a balance between positive and 
negative problems and used emotion-focused strategies to work towards religiousness or 
spirituality goals.  
Interestingly, though Rapkin and Schwartz (2016) found that problem-focused coping 
improved PCS, Pakenham (1999) deduced that problem-focused coping might be related to PCS 
and MCS because people with MS must solve practical problems associated with a disability.    
In a crossectional analysis, Pakenham proposed that problem-focused coping will be more 
evident at stressful events leading to better adjustment, therefore better overall Perceived Health 
Status and coping.   
In a sample (N = 96) of people with relapsing and progressive MS, Perceived Health 
Status was assessed using a five-point scale developed by the researcher, rated from 1= excellent 
to 5 = extremely poor.  Regression analyses of the effects of stress and coping on Perceived 
Health Status indicate that people who used more problem-focused coping strategies  
(R2 = .37, p < .01) had a better adjustment and Perceived Health Status over time.  In contrast,  
higher levels of emotion-focused coping were associated with more distress (r = .69, p < .01) and 
depression  (r = .55, p < .01). Though adjustment to MS requires both problem and emotion-
focused strategies over time, emotion-focused coping strategies such as avoidance and wishing 
for a better life are associated with high-stress levels.  
Wilski and Tasiemski (2016) reported that cognitive appraisal and reappraisal by people 
with MS are essential correlates of Perceived Health Status.  One hundred and seventy-two 
women and 85 men (N = 257), with relapsing-remitting MS (RRMS, 37%), primary progressive 





(PRMS, 8%) were recruited to investigate the relationship between cognitive appraisal and 
Perceived Health Status. The 29-item Multiple Sclerosis Impact Scale was used to measure 
Perceived Health Status (Hobart et al., 2001).   
Wilski and Tasiemski (2016) demonstrated that patients with troublesome symptoms and 
more disability had increased self-identity with MS resulting in worse PCS                                
(R2 = 0.45, p  0.001). This finding is similar to Rapkin and Schwartz’s (2016) discussion on 
cognitive appraisal, indicating that participants with poor PCS had a negative frame of reference 
about MS.  Regarding MCS, Wilski and Tasiemski found that self-esteem ( = - 0.41, p  0.001) 
was the best predictor. It is reasonable that better self-esteem results in better confidence to 
manage MS and its consequences. Thus, if an individual with MS thinks positively of themselves 
and their ability to achieve personal health goals that may lead to better physical and 
psychological outcomes, it influences Perceived Health Status. 
Interestingly in Wilski and Tasiemski’s (2016) study, the type of MS, relapsing or 
progressive, or how long the person had the disease did not significantly influence Perceived 
Health Status.  Both Rapkin and Schwartz (2016) and Wilski and Tasiemski (2016) demonstrated 
that psychological influences such as feeling good about themselves and being married led to 
better Perceived Health Status.  Perhaps being married gave the person more social and 
emotional support to manage the consequences of the disease. However, predictably, in both 
studies, there was an association between more disability (β = 0.34, p  0.001) and lower scores 
on overall Perceived Health Status. So we know people with MS face many physical challenges 
which negatively impact Perceived Health Status, but how do people with MS compare to the 





Pittock et al.'s (2004) study on self-reported Perceived Health Status for patients with MS 
compared to normative data for the general US population noted that, for people with MS,  
Perceived Health Status remained stable over time despite increasing physical disability. They 
used the Multiple Sclerosis Quality of Life Health Survey (MSQoL-54) (Vickrey, 1995) to 
measure Perceived Health Status. The MSQol is a combined version of the SF-36                  
(Ware & Sherbourne, 1992) with 18 additional items pertinent to MS. In the cohort (N = 185), 
participants were diagnosed with relapsing, secondary or primary progressive MS with a median 
age of onset of 31 years and a median disease duration of 19.3 years. As expected, longer disease 
duration with resulting physical disability led to significantly worse Perceived Health Status in 
the people with MS (r = - 0.37; p < .001). Additionally, mean scores in Perceived Health Status 
were lower (M = 39.2, SD = 12.7) in the people with MS compared to normative mean (M = 50 
± 10) scores for the general US population.  
Because MS can cause profound physical deterioration, it was expected that physical 
domains of Perceived Health Status for those with MS, particularly physical functioning         
(M= 36.8, SD =17.4), would be worse than the normative mean score (M = 50 ± 10) for the 
general US population. As expected, regardless of age, people with more disability           
(whether with MS or not) had worse PCS than people with minimal or no physical disability                           
(M = 39.2, SD = 12.7). Regarding MCS however, the overall MCS of the people with MS were 
not lower than the general population (M = 50 ± 10) studied but notably were better (M = 54.2, 
SD = 8.6, p < .001). Notably, there were no significant relationships in some subset of MCS and 
physical disability particularly role emotional and disease duration (r = - 0.05, p = .46) or mental 





These findings are similar to those of Rapkin and Schwartz (2016), who also found that 
psychological health was not statistically significantly affected by disability. In general, 77%     
(n = 142) of the patients in Pittock et al.’s (2004) study were mostly satisfied or delighted about 
their lives. Why physical disability does not significantly influence psychological health status 
may be influenced by coping mechanisms that help patients adjust to health situations allowing 
them to compensate psychologically. The cross-sectional analysis suggests that psychological 
status demonstrates little change in MS patients, but how is it impacted over time in people    
with MS?  
Tepavcevic et al. (2014) noted that in a cohort of patients (N= 93) followed for three and 
six years, both the PCS and MCS deteriorated over time. Tepavcevic et al.’s results contrast with 
other longitudinal cohort studies (Hopman, Coo, Brunet, Edgar, & Singer, 2000), showing the 
mental component scores' stability over time. The MSQoL-54 (Vickrey, 1995) was used to assess 
Perceived Health Status in Tepavcevic et al.’s(2014) study. Participants were 18 - 60 years of age 
and diagnosed with relapsing, secondary progressive, and primary progressive MS with a gender 
distribution of males (n = 27) and females (n = 66).  
Tepavcevic et al.'s. (2014) analyses of changes in Perceived Health Status's magnitude 
over the first three years showed a medium effect size for Perceived Health Status (−0.54). 
Additionally, by six years, there was further deterioration in Perceived Health Status, resulting  
in a large ES (≥ 0.80) (p < 0.01). Changes in the MCS (r = −0.474, p < 0.01) and  
PCS (r = −0.727, p < 0.01) were negatively correlated with the changes in the disability scores 
during the entire study period. Therefore, as physical disability worsened, patients reported 





In Tepavcevic et al.’s. (2014) study, all aspects of Perceived Health Status changed over 
time from baseline and at 3-years and 6-years, most notably in patients with lower disability at 
baseline.  Explanations may be that people who have little physical effects of MS initially may 
not have developed adequate modes of adaptation in coping with disability. Therefore, as levels 
of disability rise, people with MS face significant adverse effects on basic self-care and 
functioning, becoming more dependent on others leading to worse Perceived Health Status.  
The aim of measuring health status in people with MS is to help tailor clinical 
interventions and assess their effectiveness in routine care. Knowing a patient’s Perceived Health 
Status may indicate patients’ priorities for treatment. For instance, if a person is more concerned 
about and rated MCS low, psychological interventions may be prioritized. Additionally, shared 
decision-making to help specify patients’ preferences and priorities for treatment may help 
patients cope and adhere to DMTs over time (Solari, 2005). Collaborative care requires patients 
to be involved in all aspects of treatment and consider their choices (LeBlanc et al., 2009) when 
recommending DMT use.  Furthermore, collaborative care depends on how patients and 
healthcare providers share information relevant to clinical outcomes that foster shared decision-
making.  Perhaps then patients may be more apt to adhere to recommendations for DMT. 
Adherence To DMT 
Due to variable disease progression, the uncertainty of relapses, and side effects of DMT, 
adherence is hard for MS patients (Bruce et al., 2016).  In people with MS, adherence to DMT 
has been estimated to be between 18% to 45% (Portaccio & Amato, 2009; Río et al., 2005).  
Even with good adherence, MS patients may still experience relapses and not have       





evidence that when DMT is started early and patients are persistent with therapy, treatment 
efficacy is improved (Bruce & Lynch, 2011). 
Additionally, people with MS must cope effectively with the stress of adhering to 
medications that offer no immediate benefits but have implications for good long-term outcomes 
(Beatty et al., 1998).  Unlike an infection that goes away with treatment, MS symptoms may  
not go away, and patients often have a residual disability. Thus, healthcare providers'      
challenge  is working with patients to help them see the benefits of long-term DMT use in 
lessening  disease progression.   
Adherence Defined 
The World Health Organization (WHO, 2003) defines adherence as: “the extent to which 
a person’s behavior – taking medication, following a diet and executing lifestyle changes 
corresponds with an agreed recommendation from a healthcare provider.” (p. 17). In the context 
of research trials in MS, assessing adherence is varied. Operationally adherence is defined as 
follows: not missing any prescribed dose (Devonshire et al., 2011; Treadaway et al., 2009) 
medication possession ratio (MPR) (≥ 80% is considered adherent) (Kozma et al., 2013; Tan et 
al., 2011) and diary self-report on a scale of poor to good based on the number of missed doses 
(Hupperts et al., 2014) that the researcher defines. Because the definitions of adherence are 
varied, cross-study comparisons often pose a challenge (McKay et al., 2017). 
Importantly, subjective measures of adherence, which are standard practice, may 
overestimate the degree to which patients are adherent. However, there is no single measurement 
of adherence that is optimal (WHO, 2003). Subsequently, clinicians often use multimethod 
approaches that are reliable and valid with a combination of patient self-reporting and objective 





adherence as essential to treatment efficacy. Therefore early identification and timely 
interventions of factors that affect adherence are necessary to help patients. As MS progresses, 
there is evidence that Perceived Health Status deteriorates. Clinicians may help to mitigate the 
effects of MS by focusing on Adherence to DMT. There is evidence that Adherence to DMT over 
the long term can help slow disease progression, thereby improving the physiological and 
psychological domains of Perceived Health Status in people with MS. 
Factors Influencing Adherence 
Social support, hope, self-efficacy, perceived treatment benefit, and injection anxiety 
contributes to DMT adherence in MS (Bruce, Hancock, Arnett, & Lynch, 2010; Siegel, Turner, & 
Haselkorn, 2008; Turner, Sloan, Kivlahan, & Haselkom, 2014).  Devonshire et al., (2011) 
reported the greater odds of having better adherence include being female ((OR) 1.25; 95% (CI): 
0.99 –1.56; p = 0.0572), being satisfied with DMT therapy ((OR) 1.54; 95% (CI): 1.20 –1.98; p = 
0.0007) and having family support ((OR) 1.33; 95% (CI): 1.06 –1.67; p = 0.0157).    
Treadaway et al. (2009) explored adherent and non-adherent drug-taking behavior in 
patients with MS in a multicenter observational study. The researchers aimed to understand from 
the patient’s perspective why medications were omitted and determine if missing doses impacted 
future adherence.  The MSQoL (Vickrey, 1995), a combined version of the  SF-36 (Ware & 
Sherbourne, 1992) with 18 additional items pertinent to MS, was used to measure Perceived 
Health Status. Adherence was defined as a medication possession ratio (MPR) > 80 %.  MPR is 
the total number of a drug available to the patient during any period to meet prescribed doses.  
The drug data was obtained from pharmacy refill records and noted as a percentage of time 
patients have the medication available for use (Kozma et al., 2013). Participants were eligible for 





injectable disease-modifying agent for at least six months, and had access to the internet. The 
survey instruments were all administered via the internet.  
The participants were recruited mostly (66%) from academic medical centers to complete 
the study. The majority of participants were female (77%), with an average age of 43 years.  
Patients who were older (M = 37.0 ± 9.16)) at disease onset had significantly                               
(t = 2.17, p = .0002) better adherence than younger patients (M = 34.6 ± 8.69).  It may be 
difficult for someone newly diagnosed, younger, and symptom-free to accept an MS diagnosis 
and start treatment with DMT with side effects. It is also possible that older people with MS who 
may have the longer medication-taking experience had better insight and knowledge into how 
DMT may affect disease course. 
As expected, adherent patients had higher scores on both the PCS (M = 59.7 ± 20.7,        
p = 0.0020) and MCS (M = 69.5 ± 20.5), p < 0.0001) of Perceived Health Status compared to 
patients who reported nonadherent behaviors in PCS (M = 55.2.± 19.7) and MCS (M  = 63.1 ± 
21.6) (t statistics not reported). So patients who cognitively appraise changes in health and take 
steps to cope with the changes by being adherent to DMT have better Perceived Health Status 
than those who are not adherent and may be unable to cope with MS's challenges. 
Munsell, Frean, Menzin and Phillips (2016) found, in a cohort (N = 8382) of people with 
MS, that age range older than 18 – 34 years was significantly associated with a higher likelihood 
of adherence: 45 to 54 years ((OR) 1.33; 95% [CI]: 1.178 - 1.505, p < 0.0001) and 55 - 64 years 
((OR) 1.321; 95% [CI]: 1.318  1.533, p = 0.0003). However, the odds of being more adherent 
with oral versus injectable DMT were not significant                                                               
((OR) 1.062; 95% [CI]: 0.937–1.202; p = 0.3473) in any age group.  One would expect that 





was at most three times weekly, and an oral DMT is prescribed to be taken one to two times 
daily.  Thus it would be expected that patients may forget to take all oral doses as           
prescribed — the more complex the medication regimens, the more likely that adherence 
decreases (Kalogianni, 2011).   
Males (95% [CI]: 1.085–1.335; p = 0.0005) were 1.2 times more apt to be adherent than 
females which is in contrast to another study (Devonshire et al., 2011) reporting females with 
1.25 (95% [CI]: 99–1.56; p = 0.05) better adherence than males. Notably, the male-to-female 
adherence rate has been inconsistent across studies (Turner, Kivlahan, Sloan, & Haselkorn, 2007; 
Zhornitsky et al., 2015).  It may be possible that males are more adherent because of the social 
stigma of disability and the idea that better adherence may lead to better physical outcomes. 
Depression at baseline ((OR) 0.618; 95% [CI]: 0.511–0.747; p < 0.0001) was also predictive of a 
lower likelihood of adherence. People who are depressed may not have the drive to do what is 
necessary to adhere to treatment. Therefore, lower rates of adherence may be possible in 
depressed people.  
Of  89 patients with MS who were on a DMT, those who perceived benefits of therapy at 
four months and six months reported better adherence (80% or better) than those who did not 
perceive a benefit of therapy (Turner et al., 2007).  The sample population was representative of 
the population of army veterans with MS in the US. Adherence was measured with selected 
items from the Adherence Determinants Questionnaire (ADQ) (DiMatteo et al., 1993).  All 
participants were on an FDA-approved injectable DMT. The MS diagnosis length was            
11.79 (SD + 7.95) years and taking the current DMT for 3.43 (SD = 3.29) years. There was 
significantly better adherence in the group that believed there was a benefit in taking DMT that 





six months, ((OR) 2.49; [CI]: 1.01–6.17, p < .05). These results are supported by           
Treadway et al.’s. (2009) study on factors that influence adherence to DMT where 80% of 
adherent patients cited slowing MS progression and decreasing neurological attacks as the most 
crucial benefit of adherence.  The longer the patients were on DMT, the better the adherence, 
perhaps because as the disease progresses and symptoms become more evident, patients cope by 
adhering to try and mitigate MS's disabling effects. In Turner’s (2007) study, 80% adherence 
was achieved by over 80% of the participants, which is higher than and is in contrast to 
adherence estimates in MS (Heesen et al., 2014). 
Zhornitsky et al. (2015) reported that, over 12 years, 50% (N = 1471) of patients who 
started DMT discontinued the drug. Patients who were > 18 years old with relapsing MS on an 
injectable DMT at an MS clinic participated in the study. Mean age was 38.4 (SD = 9.3) years, 
75% were women, and mean MS duration was 6.0 years (SD = 6.7). Patients who were younger 
18 - 30 years were 7.8 times more likely to stop DMT sooner (95% [CI] (6.0 - 9.9) p < 0.0001) 
than patients who were 31 - 73 years. Across the study, demographic variables such as route of 
administration and type of DMT did not significantly impact adherence rates.  
A common thread in all the reported adherence study outcomes was that younger patients 
were more apt to have less adherence than older people with MS. It has been reported that 
treatment failure is more easily detected in younger patients with less disability because relapses 
are more common before the disease reaches the progressive phase (Mowry et al., 2009).  If the 
frequency of relapses does not decrease, patients may have no confidence in the DMT and are 





Adherence To DMT And Perceived Health Status In MS 
Devonshire et al. (2011) found that overall adherence to DMT was 75% in a multicenter 
observational international study that included the US (N = 2566). Participants were ≥ 18 years 
of age at the time of enrollment, had a documented diagnosis of relapsing-remitting MS,         
and were on monotherapy with their current DMT for at least six months before enrollment.   
The MusiQoL ((Vickrey, 1995) was used to measure Perceived Health Status. The MusiQoL      
is another name for the MSQoL-54 (Vickrey, 1995). The study's adherence was defined             
as not missing a single dose of DMT within four weeks before the study began based on     
patient self-report. 
Most patients (70%; N = 1923) in Devonshire et al.’s (2011) study with a mean exposure 
to DMT for 31 months took their DMT as prescribed. Adherent patients on all injectable DMT 
had better Perceived Health Status in all dimensions, particularly physical well-being                 
(p < 0.0001, t not reported) than non-adherent patients. Patients who were adherent to DMT    
had less neuropsychological impairment with a significantly lower score of 18 (better)               
on an MS neuropsychological impairment questionnaire than non-adherent patients (n = 175: 
median = 22.0; p < 0.0001).  In this large cohort, a significant 75% of patients who had better 
adherence to DMT rated their Perceived Health Status better.  The results indicate that adherence 
to DMT can significantly affect the PCS and MCS of Perceived Health Status regardless of the 
type of DMT. There were fewer neuropsychological impairments in adherent people, showing 
that perhaps starting and staying on therapy does mitigate some of the damage from MS.  
Therefore studies that can find approaches to improve adherence to DMT over the long term may 





In a prospective observational study on DMT adherence, Coyle et al. (2014) established 
that MS participants (N =2966) with increasing levels of medication possession ratio (MPR) 
remained relapse-free over a 24 month study period. Inclusion criteria were people ≥ 18 years 
old, diagnosed with MS, and taking an FDA-approved DMT.  Study measure for Perceived 
Health Status was the Short Form Health Survey 12 items (SF - 12v2©) (Hays et al., 1995), 
which is a shorter version of the SF-36 Health Survey (Ware & Sherbourne, 1992) that uses just 
12 questions to measure Perceived Health Status.  The participants' mean age was 49 years      
(SD = 10.3) and was 80% female.   
Coyle et al.’s (2014) objective was to determine how adherence to DMT was associated 
with health outcomes.  In the study, time since diagnosis ranged from less than one year to 47 
years, and 75% of the participants had relapsing MS. Overall, the lowest mean scores and worst 
quality of life assessments were found on PCS (M = 40.9 ± 13.2) and role physical (M = 41.2 ± 
11.9) subscales, while one of the highest scores was in the MCS (M = 47.4 ± 10.7).  
The findings of Coyle et al. (2014) were consistent with Steinberg, Faris, Chang, Chan, 
and Tankersley (2010), who found that, over three years, an MPR ≥ 85% was associated with      
a decreased risk of relapse compared to an MPR ≤ 50%. Steinberg et al.’s. (2010)                      
non-experimental retrospective analysis of (N = 1606) of participant’s prescription claims data 
assessed relapse rates and healthcare utilization based on MPR. The study population was ≥ 18 
years old, and 76% were female. The data showed an increasing adherence trend over three 
years, from 72% to 76%.  However, as adherence decreased, mainly in 5% decrements, there was 
an increased risk for relapse. Additionally, there was a significantly higher risk                          





Steinberg et al. (2010) also found significantly decreased healthcare resource utilization 
for inpatient admissions (RR 0.79; 95% CI 0.65 - 0.98), p < 0.05) and fewer emergency room 
(ER) visits (RR 0.78; 95% CI 0.61 - 0.9), p < 0.05) for adherent patients.  Across studies, the 
least number of relapses were observed in groups with an MPR ≥ 85%                                        
(Cohen et al., 2015; Coyle et al., 2014; Steinberg et al., 2010), showing that better adherence not 
only resulted in better Perceived Health Status but also in better clinical outcomes. Furthermore, 
economic savings and increased productivity may be realized because of less time spent in the 
ER and on hospital inpatient stays.    
Treadaway et al. (2009) reported, in a cohort of  MS patients (N = 708), adherent patients 
(> 75% - 100% adherent) scored significantly higher than non-adherent patients in Perceived 
Health Status in both the PCS (t not reported, p = 0.0020) and MCS (t not reported, p  < 0.0001).    
The results are similar to Cerghet et al. (2010), who reported positive associations between 
increased adherence and select Perceived Health Status dimensions.   
Cerghet et al. (2010) used claims data to evaluate the association between adherence to 
DMT and patient-reported outcomes over 12 months. Eligible patients were ≥ 18 years old with 
MS.  The participants (N = 163) with relapsing MS were surveyed to collect information on 
Perceived Health Status, disease severity, and MS duration. Medication Adherence was defined 
as the percent of the time the patient had the medication available. The MSQLI (Vickrey, 1995), 
a combined version of the SF-36 (Ware & Sherbourne, 1992) with 18 additional items pertinent 
to MS, measured Perceived Health Status. Better adherence to DMT (n = 111) was associated 
with better MCS (β = 1.002, p = .04) although there was no significant association (β = 0.508, p 
=.20) with the PCS even with better adherence. The non-significant associations with PCS are 





MCS of patients with MS.  Because the MCS of patients with MS is generally better and shows 
stability in cross-sectional and longitudinal analysis, patients may adjust and learn how to 
manage the disease's consequences over time.  
The decision to adhere to DMT requires thinking about the disease effects and developing 
a plan to cope, adjust, and conform to having MS. Therefore, Adherence to DMT, a         
problem-focused coping method, may be a way to help manage the stress of MS and improve 
Perceived Health Status (Goretti et al., 2010).  Coping mechanisms help patients adjust to health 
situations allowing them to also compensate psychologically to the disease. There is evidence 
that Religious Coping, a form of emotion-focused coping, is associated with better mental health, 
adjustment, and Perceived Health Status among people with chronic illnesses (Naghi et al., 2012) 
Religious Coping 
Religion is a multidimensional construct and has been used to describe beliefs, rituals, 
sacred texts, prayers, religious attendance, and faith in a higher power (Makros & McCabe, 
2003).  When stressful health events occur, many people turn to religion, which may help them 
manage the consequences of chronic disease (Bussing et al., 2013).  People often use prayer to 
cope with stressors as a source of strength to gain control over the unknown (Gordon et al., 
2002). It is associated with greater well-being, improved coping with stress, and better mental 
health (Koenig, 2012).  
The spiritual dimensions include religion and spiritual beliefs that are intrinsic and give 
purpose and meaning to all life processes (Neuman & Fawcett, 2011). According to Neuman 
(2011), the spiritual variable is a source of strength to the person giving stability to the system. 
As a result, when a person experiences stress, they find the strength to cope by drawing upon 





team leads to better patient satisfaction reports, influencing communication, collaboration, 
coping, and adjustment (Hughes et al., 2017).   
Koenig’s (2012) meta-analysis of clinical research on religion and spirituality and 
Perceived Health Status found 37 rigorous studies where 57% reported significant positive 
relations while only 8% found no significant relationships. Pargament et al. (1998) found, 
through exploratory factor analysis, patterns of Positive and Negative Religious Coping in three 
cohorts, including hospitalized medically ill elderly. The positive and negative scales were 
significantly positively correlated (r = .18, p < .001), indicating that people use a combination of 
Positive and Negative Religious Coping methods in their efforts to manage stressors.  
Religious Coping Defined 
Religious Coping is an effort by individuals to search for significance, understand, 
manage, and come to terms with stressors in ways related to the sacred (Pargament 1997). 
Religious Coping is a process of discovering, conserving, and sometimes altering specific    
goals and values (Pargament, 2002) and is used when personal resources are limited, and religion 
is available (Harrison et al., 2001).  Therefore, religious, and spiritual concerns must be assessed 
to provide collaborative, holistic, and caring perspectives for patients.  
Religious Coping is categorized into two patterns: positive and negative           
(Pargament, 1997; Pargament et al., 1998). The positive pattern includes collaborative methods 
with the sacred. The negative pattern is evident when a person relies solely on oneself for 
spiritual guidance or submits all control over one’s life situation to a higher power, deferring 
Religious Coping.  
Negative Religious Coping is associated with religious tension and struggle, where 





to an outside force to solve their problems. They can also be self-directing by coping 
independently without relying on God’s help (Pargament, 1997). Positive Religious Coping 
strategies are helpful to people under stress because the person has a secure relationship with the 
sacred collaboratively and sees stress as a transformative force in their lives (Pargament, 1997).  
People who use Positive Religious Coping have a comprehensive view of the world that 
is good-natured. Positive collaborative Religious Coping has been linked to better physical 
health (Bjorck & Thurman, 2007; Lee, Nezu, & Nezu, 2014; VandeCreek et al., 2004), which is 
in contrast to self-directing and deferring religious coping, which has shown mixed results 
(Pargament et al., 1998). How people use religion to cope has implications for clinical outcomes. 
Notably, people who utilize Negative Religious Coping see disease and health problems as an act 
of the divine that they cannot change or make better, so self-care may be affected. Alternatively, 
Positive Religious Coping methods can motivate the person to act, transforming or reconstituting 
to a new normal to take care of body and spirit. 
Religious Coping And Health Outcomes 
Controlling for secular variables, negative Religious Coping was a significant predictor 
of poor health outcomes (Sherman et al., 2005; Tsevat et al., 2009).  Sherman et al. (2005) 
hypothesized that Religious Coping rather than general religious orientation would be 
significantly tied to health outcomes in cancer patients.   
In Sherman et al.’s. (2005) study participants (N = 213) with multiple myeloma were 
predominantly Christian Protestants (approximately 87%), with smaller proportions of Catholics, 
Jews, Muslims, nonreligious individuals, and those from other affiliations. Religious Coping was 
assessed using the Brief RCOPE (Pargament et al., 2011), and the SF-12 (Ware, 1995) measured 





component score (PCS) (r= -.18, p < .01) and mental component score (MCS) (r = −.29, p 
< .0001) used more Negative Religious Coping compared to those who use Positive Religious 
Coping. Negative Religious Coping was associated with more pain (β = -.19, p < .01), less 
energy (β = -.21, p < .01) and worse health outcomes (β = -.15, p < .05).   
Tsevat et al. (2009) measured Perceived Health Status in people with HIV before and 
after diagnosis to determine if health status changed over time and whether spirituality/religious 
coping affected the outcome.  The HIV/AIDS-Targeted Quality of Life (HAT-QoL) (Holmes & 
Shea, 1998) measured Perceived Health Status and, the Brief RCOPE (Pargament et al., 2011a) 
measured Religious Coping.  Participants (N = 347) were interviewed twice, 18-months apart, 
and 273 (79%) identified most commonly as Roman Catholic, Baptist, or Southern Baptist. Use 
of Positive Religious Coping methods before diagnosis improved odds (OR 1.07, 95% CI: 1.02–
1.12, p = 0.008) of better Perceived Health Status and health outcomes after diagnosis. Religious 
Coping in this sample persisted across time to help the participants cope with improving 
Perceived Health Status and adapting to an HIV diagnosis.   
Freitas et al. (2015) examined the influence of Religious Coping and quality of life in 
people (N = 147) with inflammatory bowel disease (IBD).  Religious Coping was measured with 
the Brief RCOPE (Pargament et al., 2011), and Perceived Health Status was measured with the  
World Health Organization Quality of Life Instrument-Abbreviated version (WHO | The World 
Health Organization Quality of Life (WHOQOL), n.d.).  The participants identified primarily as 
Roman Catholics and Protestants. 
In the sample, better Perceived Health Status was independently associated with higher 
Positive Religious Coping (β = 0.196, p = 0.022).  Additionally, more depression was associated 





with IBD face significant challenges that require coping with chronic disease and adapting to 
lifelong changes. Positive Religious Coping in the participants was associated with better 
Perceived Health which is consistent with Sherman et al. (2005) and Tsevat et al. (2009).  
Understanding the differences in how religiousness and spirituality impact health 
outcomes can help shed light on how Religious Coping differs and why Religious Coping may 
be a better indicator of coping with chronic disease. McCullough and Laurenceau (2005) 
examined religiousness with Perceived Health status over the adult life span. The researchers did 
a retrospective analysis of data (N = 1119) from an original sample born in 1910 who have been 
contacted over the years for follow-up surveys. Participants were Protestant, Catholic, Jewish, 
and 45% indicated no church affiliation. The participants’ data had at least one measure of 
Perceived Health Status. They were at least 20 years of age and had been in the original study for 
59 years. Perceived Health Status was measured 11 times using a 5-point Likert scale where 1 = 
very poor to 5 = very good.  Religiousness was measured with a single item using a 5-point scale 
(1 = none to 5 = very much).  It should be noted that religiousness denotes involvement in 
religious activities. There was a significant relationship between religiousness and Perceived 
Health Status only in women (r = .71, p < .05).  For men, the relationship was weak and         
non-significant (r = .08).   
Koenig, George, and Titus (2004) examined religiousness and spirituality as correlates of 
better psychological and physical health in older patients. The participants (N = 838) aged 50 
years and older with a range of medical diagnoses for infectious, heart, pulmonary and 
gastrointestinal diseases were religiously affiliated primarily as Baptist, Methodist, Pentecostal, 
Catholic, Presbyterian, and Episcopal. Self-rated spirituality and religiousness were measured on 





poor = 1 to excellent = 6.  Greater intrinsic religiosity was associated with fewer depressive 
symptoms (β = 0.16, p < 0.01).  Being both spiritual and religious was associated with less 
impairment in activities of daily living (β = -0.06, p < .05).  Better Perceived Health Status was 
associated with being religious, not spiritual (β = .10, p < .01), and being spiritual not religious 
(β = .01, p >.05) had no association with better Perceived Health Status. The participants in the 
study who were among the most debilitated must cope with significant illness and disability.  
Although the relationships of religion and spiritual characteristics with physical outcomes were 
weak, there are limitations on the role religion and spirituality have in decreasing disability.  
However, Religious Coping can positively influence psychosocial outcomes allowing people to 
successfully cope with illness, adjust to changes and decrease depression.   
Religiosity and religious/spiritual beliefs are frequently used to cope with illness. People 
who identify as religiously motivated have less depression and better Perceived Health Status, 
allowing these individuals to adjust and integrate changes into their lives which were also 
evident in McCullough and Laurenceau’s (2005) study.  Pargament, Koenig, Tarakeshwar, and 
Hahn (2004) examined Religious Coping as a predictor of both psychological outcomes (quality 
of life, spiritual outcomes, and stress related growth) and physiological outcomes (activities of 
daily living (ADL)), depression, and cognitive functioning, over two years.  The participants    
(N =268) were medically ill, hospitalized elders, and 95% identified their religious affiliation as 
Christian. The Brief RCOPE ( Pargament et al., 2011a) measured Religious Coping at follow-up.  
Separate hierarchical regressions were run for each dependent variable. Because this was 
longitudinal data, demographic variables, baseline health (functional status and depression), and 
mortality, and selective attrition was entered on each analysis's first regression step.  Positive and 





change on the second step. Higher Positive Religious Coping resulted in better spiritual 
outcomes (.32, p < .001) and stress related growth (.32, p < .001) but quality of life (.00) 
depressed mood (.02), ADL’s (.04) and cognitive functioning (.05) showed no statistically 
significant changes. Higher Negative  Religious Coping was related to worse spiritual outcomes 
(-.11, p < .05), worse quality of life (- .13, p < .01) and more depression (.15, p < .001) but better 
ADL‘s (.20, p < .05).  Negative Religious Coping had no statistically significant effect on stress 
related growth (-.12) or cognitive function (-.04). Thus, patients using Positive Religious Coping 
appear to be somewhat more able to adapt and cope with health changes over time. 
Cross-sectionally and longitudinally, Positive Religious Coping is an emotion-focused 
coping strategy that may influence Perceived Health Status by changing personal views of 
health, allowing people to adapt over time. Therefore, Religious Coping is an essential factor to 
consider when attending to medically ill people's health and well-being.  People turn to religion 
to cope with things they do not understand, and Religious Coping may have implications for 
better long-term psychological outcomes.  
Religious Coping And MS  
Spiritual well-being and health outcomes have been explored in people with MS (Bredle, 
Salsman, Debb, Arnold, & Cella, 2011; Ghabaee, Bagheri-Nesami, & Shafaroudi, 2016).  
However, the research literature is scant concerning Religious Coping and MS. No studies on 
Religious Coping using the Brief RCOPE and Perceived Health Status in people with MS have 
been done.  Studies outside the US in Iran on people with MS have found an association between 
religion and Perceived Health Status (Vizehfar & Jaberi, 2017).  Iran is primarily Islamic; 
therefore, the results may not be meaningful in the US, where Christians make up 70.6% of the 





only published literature on patients with MS and religious beliefs, but studies on Religious 
Coping in other disease states in the US have been done.   
Vizehfar & Jaberi (2017) assessed the relationship between religious beliefs and 
Perceived Health Status cross-sectionally using the SF-36 (Ware & Sherbourne, 1992) and the 
Duke University Religion Index (DUREL) questionnaire (Koenig & Büssing, 2010) with          
(N = 145) MS patients. The study participants were primarily female (85.5%), with a mean age 
of 30.21 and diagnosed with MS for 2.52 ± 3.76 years.   
In the participants, religious variables determined a non significant 5.3% of the changes 
in PCS (R² = 0.05, p = 0.66) and 2.1% of the changes in MCS (R² = 0.021, p = 0.58) therefore 
religious variables in this population were not predictors of physical or mental component scores 
in Perceived Health Status. Additionally, the study only observed religiousness and not Religious 
Coping in the context of MS. Although a more homogenous religious society such as Iran may 
not reflect the US's sociocultural context, it was worthy of evaluating the results.  
In a cohort of individuals who were at least 18 years old and were HIV positive, the 
Religious Coping Scale (RCOPE) (Pargament, Koenig, & Perez, 2000) a more extended version 
of the Brief Religious Coping Scale (Brief-RCOPE) (Pargament, Feuille, & Burdzy, 2011) was 
used to measure Religious Coping. The HIV/AIDS-targeted quality of life (HAT-QoL) (Holmes 
& Shea, 1998) was used to measure HIV/AIDS Perceived Health Status (Lee, Nezu & Nezu, 
2014). Because HIV can now be classified as a chronic disease (Deeks et al., 2013), cross-
comparison to MS may yield noteworthy results.   
The participants' mean age was 44.89 years (range 20 - 73), 60.5% were male, and the 
average length of diagnosis was 13.31 years.  The gender difference in the participants contrasts 





cohort with HIV (N = 198), higher Negative Religious Coping scores were negatively correlated 
with overall Perceived Health Status (r = -.39, p < .001). Therefore, as Negative Religious 
Coping increased, there was a corresponding decrease in Perceived Health Status. As expected, 
Negative Religious Coping, where people often focused on the negative aspect of stress leading 
to maladaptive coping such as self-blame and God’s will, was associated with poor Perceived 
Health Status. People may have felt hopeless and despondent in the face of a devastating illness 
that often leads to early death and, as a result, poor Perceived Health Status.   
VandeCreek et al. (2004) found that Positive Religious Coping (r = 0.29 p = .01) was 
correlated with better management of the stress of rheumatoid arthritis (RA), another chronic 
disease that can lead to physical disability and dependence on a caregiver.  In the cohort of 
people with RA (N=181), the nonreligious coping inventory (COPE) (Carver et al., 1989) and the 
RCOPE (Pargament et al., 2000) were used to examine Religious Coping and nonreligious 
coping. The participants had a mean age of 59 (SD 1.04) years, and 86% were female. The 
gender distribution is similar to people with MS. Roman Catholics were 55%, Protestants 22%, 
and 23% reported other religious heritages such as Judaism. The length of time since RA 
diagnosis was (M = 18 (SD) ±0.97 years).   
Non-religious coping methods are used to find meaning in life situations and have an 
emotional or problem-solving focus. Consequently, there was a 70% correlation between the 
COPE subscales (Carver et al., 1989) and the RCOPE (Pargament et al., 2000) that describe 
emotional or mental coping methods. Positive Religious Coping was associated with religious 
helping and focus (β = 0.309; 95% CI 0.107 - 0.512).  Indicating that individuals who viewed 






Negative Religious Coping was associated with depressive symptoms (β = 0.111; 95% CI 
0.083 - 0.139); however, there was no significant correlation with non-religious coping.  
Therefore, depressed individuals used more Negative Religious Coping methods over non-
religious methods to cope with illness and life stress. Negative Religious Coping, mainly passive 
reappraisal, demonic reappraisal, marking religious boundaries, and interpersonal discontent, are 
more emotion-focused coping strategies. Overall, Religious Coping seems to have an emotional 
versus a problem-solving focus, is related to less depressive symptoms, and can help or hinder 
coping, facilitate adjustment to chronic disease such as Adherence to DMT and improve overall 
health perceptions.  
Summary  
The stress of MS disrupts the usual defenses of an individual, resulting in lower 
physiological (PCS) and mental (MCS) dimensions of Perceived Health Status and disruption to 
the system's Lines of Defense. Efforts to appraise the situation, devise a plan of action, and bring 
about a new normal; Reconstitution of the system activates problem and emotion-focused coping 
strategies to manage the disease's consequences. Adherence to DMT which requires effective 
problem-focused coping skills can help patients to mitigate the disability trajectory in MS.  
Positive Religious Coping, a form of emotion-focused coping strategy, has shown good results in 
helping patients to adjust what normal looks like with an MS diagnosis. Reconstitution allows 
individuals to adapt to MS's changes and effectively cope with the consequences of the disease to 








In this descriptive correlational cross-sectional study, a random sample of adults with MS 
was used to gather data to explore the relations between the dependent variable Perceived Health 
Status and the independent variables Adherence to DMT and Religious Coping.  Participants 
were contacted by e-mail and invited to complete the RAND 36-Item Health Survey (Ware, 
2000) (see Appendix B), MS-TAQ Barriers subscale (Wicks, Massagli, Kulkarni, & Dastani, 
2011) (see Appendix C), The Brief RCOPE (Pargament, Feuille, & Burdzy, 2011) (see Appendix 
D), and a personal demographic data sheet (see Appendix E).  Relations among variables were 
analyzed using multiple regression analysis of variance with alpha set at .05 and power at .80 
with an anticipated effect size of .065.   
Sample 
The calculated sample size for the study was 172 participants ≥ 18 years old in the US 
with MS who are currently on an FDA-approved DMT prescribed by a health care provider.  
Thus a priori calculation of sample size was done using GPower (Faul, Erdfelder, Lang, & 
Buchner, 2007) based on the above stated .05 alpha, .80 power, and an anticipated effect size 
of .065.  Although Cohen (1992) suggests anticipating a medium effect of .15, an effect size 
of .065, which is midway between a small (.02) and medium (.15) effect was chosen based on 
reported results in the literature for relations between perceived health status and adherence (.10 
- .37 ) and perceived health status and religious coping (.05 - .39) (Pittock et al., 2004; Rapkin & 
Schwartz, 2016; VandeCreek et al., 2004; Vizehfar & Jaberi, 2017).  To obtain a representative 





(NARCOMS) provided access to adult MS participants in the US interested in participating in 
the study.  The North American Research Committee on Multiple Sclerosis (see Appendix G) 
only provided recruitment assistance.   
The focus of NARCOMS is creating and maintaining a database of individuals’ 
experience with MS and making that information available to researchers who can use it to help 
people with MS and others and for studies conducted by experts within the NARCOMS 
consortium.  A confirmation study of  240 randomly selected participants done by Marrie, Cutter, 
and Tyry (2007) determined the diagnostic accuracy of MS as reported by registry participants. 
Of the 240 participants, only (N = 142) were active participants, and (N = 81) completed the 
study.  Marrie et al. (2007) determined that 98% of the respondents had a confirmed MS 
diagnosis based on medical records review and treating physician diagnosis. Stratified sampling 
was used to compare the characteristics of responders to non-responders. There were no 
significant differences between responders and non-responders in gender (p = 0.44), race (p 
= .84), education (p = .60), and income (p = 0.62). The database supports the validity of an MS 
diagnosis as reported by registry participants. 
The registry, an active database of over 38,000 persons with MS, provides a way for 
participants to supply researchers with information about their MS experience and participate in 
research studies. The participants received no compensation from participating.  The registry also 
maintains a computerized database representing at least 10% of the MS population in the US that 
tracks changes in the participants over time with updated semi-annual participant surveys.  
The Institutional Review Board at The College of Staten Island, City University of New 
York (CUNY) approved the study (see Appendix F). Six hundred randomized participants from 





prescribed an FDA-approved DMT were invited to participate in the study. The participants were 
notified via email by NARCOMS and provided with a link (SurveyMonkey) for taking the 
survey online.  Each participant completed four self-report web-based questionnaires assessing 
Perceived Health Status, Adherence to DMT, Religious Coping, and a demographic information 
sheet.  Data on internet surveys of MS patients yielded response rates of 49.5% (Hadjimichael, 
Vollmer, & Oleen-Burkey, 2008), 40% (Hemmett, Holmes, Barnes, & Russell, 2004),              
and 37.5% (Wicks et al., 2011). Of the 600 participants, 277 responded for an overall 46% 
response rate. A conservative estimate of a 20% response was planned to allow for a reportedly 
relatively low internet response rate (Millar & Dillman, 2011) or respondents who did not meet 
the inclusion criteria.   
Data Collection 
NARCOMS managed all initial and follow-up e-mail correspondences to participants to 
maintain participants' anonymity. Potential participants received an e-mail with information 
about the study (see Appendix H). Additionally, participants were told the study's aggregate 
results would be published with no individual identifying information. Included in the e-mail was 
a URL link to SurveyMonkey, a web survey delivery tool. The participants contacted a 
NARCOMS designated representative if they did not wish to participate, receive further emails, 
or have questions regarding the research study. The NARCOMS representative then 
communicated with the researcher.    
All survey responses were automatically entered into a CSV data file set up by the 
investigator in advance through SurveyMonkey. The investigator then downloaded the file into 





protected by user ID and password. Participation in this survey involved minimal risk to the 
participants (see Appendix I).   
All responses were anonymous, with no identifying information on the returned response.  
Participants were informed that clicking on the link and completing the survey is considered tacit 
consent. Participants were allowed to complete the survey only once with no incentives from 
participating. Only the researcher and faculty sponsor have access to the data. Data will remain 
in an encrypted password-protected file in the researcher’s computer for at least five years and be 
kept password locked. Additionally, McAfee, an anti-virus/firewall product, protects the 
computer from internet threats. 
Instruments 
RAND 36-Item Health Survey (SF-36) (Version 1.0) 
The SF-36 (Ware, 2000; Ware & Sherbourne, 1992) measures medical and socially 
relevant differences in health status and changes in health over time and is an appropriate 
instrument for measuring perceived general health, which is not specific for any age, disease, or 
treatment group.  Of the 40 health concepts studied in the original Medical Outcomes Study 
(MOS) (N = 2293), eight concepts that factored into two summary scores were selected for the 
SF-36 (Ware, 2000). The chosen concepts represent independent objective and subjective reports 
of Perceived Health Status. The two summary scales measure physical (PCS) and mental (MCS) 
health.  
The PCS measures: physical functioning (PF) (10 items), role-physical (RP) (four items), 
body pain (BP) (two items), and general health (GH) (five items).  The MCS measures: vitality 
(VT) (four items), social functioning (SF) (two items), role-emotional (RE) (three items) and 





status over the past year. There is a total of 36 items.  However, the total score will not include 
the one item about change in health status. The SF-36 can be self-administered in ten minutes by 
the participants via written questionnaire, computer survey, or interview in person or by 
telephone to persons aged 14 years and older. 
Validity.  The aggregate summary measures - physical component summary (PCS) and 
mental component summary (MCS) -were constructed based on factor analyses of correlations 
among the eight SF-36 scales in the MOS and the general U.S. population (Ware & Gandek, 
1998; Ware & Sherbourne, 1992).  Two principal components were extracted and rotated to a 
simple orthogonal structure by the Varimax method.  Physical and mental health factors 
accounted for 82.4% of the variance in the eight scales (Ware et al., 1995).   
The SF-36 is widely used and validated in studies including patients with MS (Jenkinson 
et al., 1994; Szilasiova et al., 2011).  Freeman, Hobart, Langdon, & Thompson (2000) 
demonstrated in a cohort ( N = 149) of MS patients that the SF-36 was strongly correlated with 
instruments measuring similar concepts.  The PCS was strongly correlated with the functional 
independence measure (r = 0.68) and the expanded disability status score (r = 0.82).  The MCS 
was also significantly correlated (r = 0.58) with the general health questionnaire, which measures 
emotional status. 
 Reliability.  The reliability of the eight scales and two summary measures have been 
estimated using both internal consistency and test-retest methods across samples         
(McHorney et al., 1993). Internal consistency reliability coefficients ranged from .78 to .93       
on the eight scales (median = .85).  Additionally, Szilasiova et al. (2011) reported in a cohort of  





Scoring.  Scoring the SF-36 is a two-step process.  Per the scoring key, precoded numeric 
values are recoded and averaged according to a scoring algorithm (see Appendix C).  Summed 
scores range from 0 (poor health) to 100 (optimal health).  Lower scores indicate the person 
perceives worse possible health, and higher scores indicate better-perceived health.  All 
responses to questions are printed in a left-to-right format.  
Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) V2   
Because there are no adequate tools to quantify adherence to DMT in MS, Wicks et al. 
(2011) developed an MS-specific assessment of adherence to DMT using an online community 
sample (N = 431) of patients with relapsing and progressive MS.  Qualitative analysis of the data 
revealed vital themes relevant to the participants that were described in the literature as drivers of 
adherence to DMT: perceived effectiveness of DMT, forgetting to take DMT, pain, needle 
phobia/anxiety, adverse reactions, support and patient education, availability of help with 
injecting, and stigma or reminders of disease.  Additionally, three more themes emerged not 
usually found in the literature as drivers of adherence: coping strategies, barriers, and experience 
with DMT.  The three additional themes were included in the final Multiple Sclerosis Treatment 
Adherence Questionnaire (MS-TAQ) V2.   
In the present study, only the DMT-Barriers subscale was used to measure Adherence to 
DMT. The missed dose ratio (MDR) of the subscale quantifies adherence to DMT by 
determining an MDR based on how many missed doses, in the last 28 days, of the prescribed 
DMT the patients report. Patients who reported no missed doses were coded as a 0.  The DMT-
Barriers subscale also quantifies the extent to which the patient rated 13 barriers to adherence as 
important reasons for nonadherence and is asked only of patients who missed at least one dose in 





Validity.  Pilot testing of the draft version of the questionnaire resulted in a reference 
time change from the past 30 days to the last four weeks (28 days). Random selection of 1,209 
participants from a list of 15,000 registered MS patients yielded a 41.9% response rate for the 
final MS-TAQ. Due to patients who did not meet the inclusion criteria for the study, data were 
analyzed for 37.5% of the respondents (Wicks et al., 2011). Data analysis revealed no significant 
differences in response rate by gender (ꭓ2, 3 = 4.5, p = .02). Because older participants completed 
the survey, there was a significant difference in age (F (3,1205) = 4.860, p = .002)                    
(mean difference 2.3 years, 95% CI 0.5-4 years, p = .004) compared to those who did not 
respond. A common theme from the literature is that older patients with MS were more apt to be 
adherent to DMT than younger patients. Therefore, it is probable that higher responses from 
older patients are possible in adherence studies.   
Compared to the first ongoing population-based longitudinal study of 2,000 MS patients 
in the US (Minden et al., 2006), the MS-TAQ cohort was similar for gender (79.3% (MS-TAQ) 
vs. 77% (Minden et al., 2006), age slightly younger (MS-TAQ mean age 47 years, SD 10 vs. 
Minden et al.(2006): 51 years, SD 11), and asymptomatic for less time (MS-TAQ mean duration 
since onset: 11 years, SD 9 vs. Minden et al., (2006) 18 years, SD 11). Because the study 
selected patients who were using DMT, there was a higher proportion of patients with relapsing 
MS compared to progressive MS (MS-TAQ 72.2% (311/431) vs. Minden et al. 58%). Data 
analysis revealed similarities to other large-scale adherence studies in MS                                  
(Devonshire et al., 2011a; Treadaway et al., 2009) for age, type of MS, and adherence outcomes.   
There was a strong correlation between how often patients missed doses and the        





missed DMT doses. Based on data analysis, Wicks et al. (2011) suggest that the Barriers subscale 
is a better predictor of missed doses (r = .5) than general satisfaction questions of DMT (r = .3). 
The MS-TAQ Barriers Subscale can be self-administered in 10 minutes to adults with MS. 
Reliability.  Cronbach alpha of the MS-TAQ V2 was .82 for the DMT-Barriers subscale 
(Wicks et al., 2011). Kołtuniuk and Rosińczuk (2018) computed Cronbach alpha of 0.89 for the 
DMT-Barriers scale in a descriptive cross-sectional survey (N =226) of participants on adherence 
to DMT in MS. Kołtuniuk and Rosińczuk (2018) found no differences in age between adherent 
(37.59 ± 9.96) and nonadherent (36.43 ± 8.70) (p.0625) (p = 0.625) participants.  
Scoring.  Patients were asked how many of the previous 28 days they are to take the 
DMT, if any doses were missed, and how many. A missed dose ratio (MDR) was then calculated 
for all patients. The MDR is reported as the number of doses missed divided by the number of 
prescribed doses over 28 days. Patients who did not report missing a dose were coded as having 
an MDR of 0. Therefore, adherence rates can be calculated from 0% to 100%.   
Brief RCOPE 
The Brief Religious Coping Questionnaire (Brief RCOPE) (Pargament, Smith, Koenig, & 
Perez, 1998), developed from Pargament’s (1997) Theory of Religious Coping, is a 14-item 
measure of Positive and Negative Religious Coping with life stressors. Grounded in theories of 
religion and coping, the Brief RCOPE, a short version of the Religious COPE (RCOPE), was 
designed to provide researchers and practitioners with a practical and efficient measure of 
Positive and Negative Religious Coping (Pargament et al., 2011). The RCOPE initially 
developed for use with Christians was revised for use in religions such as Islam (Vizehfar & 





To form the Brief RCOPE, a principal component factor analysis with oblim rotation and 
constraint to two factors was done on the 105 item RCOPE. This factor analysis resulted in two 
factors: positive and negative religious coping. Item selection for the Brief RCOPE was based on 
several criteria: RCOPE items with the largest factor loadings on their respective factors, items 
that loaded on only one factor, items from a variety of RCOPE subscales, and items that were 
used in a formerly shortened version of the RCOPE used with hospitalized elderly patients 
(Pargament et al., 1998). Pargament et al. (2011) provided reliability and validity data from 
various empirical studies with samples of patients with varying medical conditions.  
Validity.  Pargament and colleagues (1998) noted that confirmatory factor analysis  
(CFA) of the 14 items from the two subscales demonstrated an acceptable fit                             
(2 = 210.77, df = 64, p < .001), given the large sample of 540 college students. They 
acknowledged that the CFA needed additional measures of fit; therefore, the chi-square to degree 
of freedom ratio was calculated and found to be 2.12. Values of less than 3.0 indicate a good fit. 
Additionally, the root square error of approximation was calculated as 0.46, which is less 
than .05, indicating a good fit (Browne et al., 2002).   
A CFA was then done on RCOPE data from a large sample (N = 551) of hospitalized 
elderly patients, and this CFA yielded similar results (Pargament et al., 1998). Notably, sample 
sizes greater than 400 in CFA may yield high values of chi-square fit indices leading researchers 
to conclude a poor model fit; therefore, additional measures of fit should be done (MacCallum et 
al., 1996). Although the chi-square is significant and not the ideal result, the Brief RCOPE is the 
most widely used measure of Religious Coping. This planned study can contribute to its further 





Reliability.  In studies across different samples of medically ill patients of various 
religious faiths, Cronbach alpha for the Positive Religious Coping subscale ranged from 0.67 - 
0.94.  Cronbach alpha for the Negative Religious Coping subscale ranged from 0.60 - 0.90.  In a 
hospitalized sample (N = 551), Cronbach α was reported as .87 for the positive scale and .69 for 
the negative scale. In a sample of (N = 213) patients with multiple myeloma, Cronbach α was .92 
for the positive scale and .90 for the negative scale (Sherman et al., 2005).  Additionally, in a 
study of outpatients (N = 450) in various stages of HIV, Tsevat et al. (2009) reported Cronbach   
α = .92 for the Positive Religious Coping scale and .82 for the Negative Religious Coping scale.   
Scoring.  The Positive and Negative Religious Coping scales are scored separately on     
a Likert scale with response options of 1 = not at all, 2 = somewhat, 3 = quite a bit and, 4 = a 
great deal. Responses are tallied across each scale item to produce a score. Scores for each scale 
range from 7 (low) to 28 (high). High scores on the Positive Religious Coping subscale indicate 
more positive Religious Coping. High scores on the Negative Religious Coping subscale indicate 
more negative coping.  
Personal Data  
The investigator constructed a demographic data questionnaire to collect information 
about personal characteristics and MS diagnosis. Some questions were taken from and modeled 
after questions from the Behavioral Risk Factor Surveillance System (BRFSS), a tool in the 
public domain (CDC, 2018). Demographic questions allow for the control of factors such as the 
type of MS, marital status, income, education, and age. 
Data Analysis 
Bivariate correlation was used to examine the relations between Perceived Health Status 





between Perceived Health Status and Negative Religious Coping. Multiple regression analysis 
was conducted to examine relations between the dependent variable Perceived Health Status and 
the independent variables Adherence to DMT and Positive and Negative Religious Coping. Data 
downloaded into SPSS version 25 (IBM SPSS Statistics for Windows, 2017) statistical software 
was analyzed for relations among the variables.  
Demographic data were used to describe the study participants and to make within and 
between-group comparisons. The data were explored to determine if the data met the 
assumptions for parametric tests. Measures of kurtosis, skewness and central tendency 
determined the normality of the data. Chi-square analysis identified whether statistically 
significant relationships exist between the participants and national data.  
 To account for participant survey data missing at random, the data was partitioned, and t-
tests were performed to check for mean differences. If significant differences existed between 








This study aimed to examine the relations between Perceived Health Status, the 
dependent variable, and the independent variables Adherence to DMT and Religious Coping.  
Based on the Neuman Systems Model (Neuman & Fawcett, 2011) and Pargament's Theory of 
Religious Coping (1977), it is proposed that Adherence to DMT and Religious Coping are 
respectively one's physiological and spiritual lines of resistance that would affect reconstitution 
to the Normal Lines of Defense, Perceived Health Status.   
These relations were tested using SPSS version 25 (IBM SPSS Statistics for Windows, 
2017) with data collected via an online survey from a randomized sample of males and females, 
18 years of age and older in the US, with a clinically definite MS diagnosis. Participants were 
taking an FDA-approved DMT for at least six months at study enrollment. 
Data Collection Results and Response Rates 
 Study recruitment was supported by NARCOMS, a project of the Consortium of MS 
Centers.  NARCOMS was solely responsible for sending an invitational email (see Appendix H) 
and communicating with 600 potential participants randomly selected from their database 
representing at least 10% (50,000) of the US MS population. The organization helps to facilitate 
confidential ways for patients to participate in research about their disease course leading to 
more effective treatments and care for people living with MS. 
  The study survey was made available for four weeks, from August 25, 2019, to 
September 22, 2019.  Weekly calls/emails between the researcher and NARCOMS involved 
reviewing response rates and responding to participants' questions. Because of the survey's high 





participants, 277 responded, for an overall 46% response rate. Two respondents did not consent 
to participate in the study, and two respondents noted that they did not have an MS diagnosis. 
These four respondents were excluded leaving 273 respondents.    
Missing data on the study variables for these 273 respondents were evaluated. Perceived 
Health Status (SF-36), Adherence to DMT (MS-TAQ), and Religious Coping (Brief RCOPE), 
6.5% (n = 18) had missing data. Of these 18 respondents, 2.56% (n = 7) did not answer any 
questions and were excluded from further analyses leaving 266 respondents (see Table 1). 
Of these 266 respondents, missing data rates for Perceived Health Status was 4.1%.  
Positive Religious Coping, Negative Religious Coping, and Adherence to DMT each totaled 
4.1%.  Because the missing value rates were < 5% of the variables' data, mean substitution 
replaced the missing values (Tabachnick and Fidell, 2018).  Analysis of the dataset before and 
after mean substitution did not significantly change the analytic outcomes. 
Table 1 
 Cases Excluded Due to Study Variables 
Criterion Not met (n) Missing data 
Did not consent 




Perceived Health Status 7 18 
Religious Coping 7 18 
Adherence to DMT 7 18 
Note: N=11. 7 respondents had overlapping criteria.  
Sample Characteristics 
Table 2 presents the characteristics of the participant population.  In the study, 81.6%     
(n = 217) of the participants were female, 88.7% (n = 236) were 45 years and older, 89.8% White 





reported having a bachelor’s degree or higher, with median household income of $50,000 - 
$75,000. Most were not working 65% (n = 173): unable to work (23.7%), unemployed (7.5%) 
and retired (33.8%). Of the 266 participants, 230 (86.5%) reported being diagnosed with 
Relapsing MS versus 36 (13.5%) diagnosed with Progressive MS.   
Table 2  
Demographic Characteristics 
Demographic characteristics  n % 
Gender 
  
Female 217 81.6 




   
Age (Years) 
  
18-24 2 0.8 
25-34 2 0.8 
35-44 26 9.8 
45-54 37 13.9 
55-64 130 48.9 




Missing 11 4.1 
Age    
45 years and older 236 88.7 
Less than 45 years 30 11.3 
   
Religion   
      Other 10 3.8 
     Christian 120 45.1 





Demographic characteristics  n % 
      Roman Catholic 39 14.7 
      Spiritual, not committed to a particular religion 32 12 
      Agnostic 25 9.4 
      Atheist 22 8.3 
      Latter-Day Saints or Mormon 2 0.80 
      Buddhist 1 0.40 
Race 
  
       White      239 89.8 
Hispanic, Latino, or Spanish Origin              9 3.4 
Black or African American  5 1.9 
Mixed Race  6 2.3 
Native American or American Indian 1 0.40 
Asian/Pacific Islander 1 0.40 
Other 5 1.9 
Marital Status   
Single 28 10.5 
Separated 173 65 
Widowed 14 5.3 
Domestic partnership 32 12 
Married 19 7.1 
   
Education 
  
Some high school, no diploma 1 0.4 
High school graduate, diploma or equivalent         17 6.4 
Trade/technical/vocational training         10 3.8 
Some college credit, no degree            36 13.5 
Associate Degree             27 10.2 
Bachelor's Degree          93 35 





Demographic characteristics  n % 
Doctoral Degree           18 6.8 
Professional Degree          10 3.8 
   
Income (USD, Combine Household, 2018) 
  
Less than 20,000        25 9.4 
20,000 - 34,000          27 10.2 
35,000 - 49,000           33 12.4 
50,000 - 74,000           37 13.9 
75,000 - 99.000            54 20.3 
Over 100.000       85 32 
Missing 5 1.9 
   
Employment   
      Unable to work 63 23.7 
      Unemployed 20 7.5 
      Retired 90 33.8 
     Employed part-time 20 7.5 
     Employed full time 73 27.4 
   
Type of Multiple Sclerosis 
  
Relapsing 230 86.5 
Progressive 36 13.5 
Note.  N = 266. 
 
Psychometric Evaluation of the Instruments 
RAND 36-Item Health Survey (SF-36) (Version 1.0)  
The SF-36  (Ware, 2000; Ware & Sherbourne, 1992) measures medical and socially 
relevant differences in health status and health changes over time. It is a suitable instrument for 
measuring perceived general health, which is not specific for any age, disease, or treatment 
group. The two summary scales measure physical (PCS) and mental (MCS) health. Summed 





health. This study’s scores ranged from 6.13 to 94.15 for PHS, 5.25 to 93.85 for PCS, and 7.00 to 
93.25 for MCS. Cronbach's alpha (Nunnally & Bernstein, 1994) was .84 (Table 3) for PHS, PCS 
was .95 and was .75 for MCS in this study.  
Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) V2  
Because there are no adequate tools to quantify DMT adherence in MS, Wicks et al. 
(2011) developed an MS-specific assessment of DMT adherence using an online community 
sample (N = 431) of patients with relapsing and progressive MS. Only the missed dose          
ratio (MDR) of the DMT-Barriers subscale quantified adherence in the present study.               
The MDR is the number of doses missed divided by the number of prescribed doses over          
28 days. Patients reporting no missed doses were coded as having an MDR of 0. Adherence 
ranged from 86% - 100%.     
Brief RCOPE   
The Brief Religious Coping Questionnaire (Brief RCOPE) (Pargament, Smith, Koenig, & 
Perez, 1998) developed from Pargament's (1997) Theory of Religious Coping is a 14-item 
measure of positive and negative Religious Coping with life stressors. Scores for each scale 
range from 7 (low) to 28 (high). High scores on the positive (PRC) and negative (NRC) 
Religious Coping subscales indicate higher positive or negative Religious Coping. In this study, 
scores ranged from 7 to 24 for PRC and 7 to 21 for NRC. Cronbach's alpha for the Brief R COPE 
scales: PRC was .96, and NRC was .84 (see Table 3).  
A principal component factor analysis was done with this study's data to explore further 
the Brief RCOPE's dimensionality as reported in the literature (Pargament et al., 2011).  





distinct clusters (PRC and NRC) that explained 62.46% of the Brief RCOPE variance. See the 
full factor analysis results in Appendix J. 
Table 3  
Psychometric Properties of Study Variables  
Variable M SD Variance Cronbach's alpha 
PHS 56.32 21.67 469.85 .84 
PCS 50.81 24.71 610.85 .95 
MCS 61.84 22.88 523.68 .75 
PRC 12.36 6.02 52.71 .96 
NRC 7.83 2.03 4.34 .84 
Note.  N = 266. 
Main Analysis 
This study examined relations between the dependent variable Perceived Health Status 
(PHS) and the independent variables: Adherence to DMT and Positive and Negative Religious 
Coping (PRC, and NRC). Data were received as an spss.sav file from SurveyMonkey.  In the 
first step, descriptive analyses were conducted, with an evaluation of normality.  
Fisher's measures of skewness (skewness/SE skewness) (see Table 4) and kurtosis 
(kurtosis/SE kurtosis) (see Table 5) an evaluation of symmetry of the distribution revealed that 
PHS was not skewed (.046) but had a negative kurtosis (-3.52) that was statistically significant.  
The PHS physical subscale (PCS) was not skewed (.928) but had negative kurtosis (- 4.16) that 
was statistically significant. The PHS mental subscale (MCS) had a negative (-2.56) skew and a 
negative kurtosis (-3.16) that were statistically significant. PRC was statistically significantly 
positively skewed (3.69) and negatively kurtosed (-.3.34), and NRC had severe positive 





Adherence to DMT had an extreme positive skew (40.33) and positive kurtosis (148.79) that was 
statistically significant. 
Table 4  
Evaluation of Skewness for Study Variables   




PHS .007 .149 .046 
PCS .142 .153 .928 
MCS -.393 .153 -2.56* 
PRC .551 .149 3.69* 
NRC 3.45 .149 23.15* 
Adherence to DMT 6.010 .149 40.33* 
Note. N = 266. *Indicates values statistically significant. 
Table 5  
Evaluation of Kurtosis for Study Variable 
Variable Kurtosis Standard Error 
of Kurtosis 
Fisher's Measure of 
Kurtosis 
PHS -1.05 .298 -3.52 
PCS -1.265 .304 -4.16* 
MCS -.961 .304 -3.16* 
PRC -.996 .298 -3.34 
NRC 13.23 .298 44.39* 
Adherence to DMT 44.34 .298 148.79* 
Note. N = 266. *Indicates values statistically significant. 
The normality of variance was measured using the Kolmogorov-Smirnov (K-S) test for 
normality with a visual examination of histograms, Q-Q, and box plots. The K-S analyses 
revealed that the dependent variable PHS (D (.072) df =266, p =.002) was statistically 





266, p < .001), NRC (D (.376) df=266, p< .000) and Adherence to DMT (D (.394) df=266, 
p<.000) were also statistically significant showing non-normal distributions.  
To examine cases that may contribute to skewness and kurtosis, Tabachnick and Fidell 
(2018) recommend screening for univariate outliers by analyzing boxplots and z-scores > 3.29 
that indicate scores unattached from the rest of the distribution. The analysis showed that the 
most extreme cases were participants 32, 69, and 164. Individual analysis of these cases revealed 
z-scores for all variables < 2.0, which is below 3.29.  
Next, a screening for multivariate outliers with analysis of residual scatterplots in SPSS 
Regression using casewise diagnostics for standardized residuals (> 3.3) was done. Mahalanobis 
distance (p < .001) and Cook's distance (> 1). Mahalanobis distance criterion is evaluated as 2 
with degrees of freedom equal to the number of variables. Cook's distance estimates data points 
that may exert undue influence and distort the regression's outcome and accuracy. Data points 
that are extreme are then checked for validity to indicate how much leverage that record may be 
influencing the regression. Leverage indicates values from records that may be so far from the 
mean that they may have an undue influence on the regression. Only case 23 had values more 
extreme from the other data points. There were no data entry errors. The data were analyzed with 
and without the case. Results revealed no significant difference in analytic results; therefore, case 
23 remained in the dataset. 
When variable data have statistically significant positive or negatively skewed and 
kurtotic distributions and violate parametric test assumptions, data transformation may be 
employed to bring the data to a more normal distribution (Tabachnick & Fidell, 2018).  The best 
use of square root transformation is when variable data has no negative numbers or zeros; 





bring the DMT data to a more normal distribution. Regarding Religious Coping, square root 
transformation did not affect outcomes and is not reported. 
  Tolerance values were examined for evidence of multicollinearity and singularity to 
identify problems that may hinder further analyses. If two independent variables are highly 
correlated, there will be uncertainty about how much variance each contributes to the dependent 
variable. Tabachnick and Fidell (2018) note that perfect multicollinearity between two 
independent variables has tolerance values of 0; therefore, high tolerance values are desired.  
Tolerance values for Adherence to DMT are .99, for PRC is .97, and for NRC is .97, which 
indicates non-multicollinearity.  
Pearson product-moment correlations for the study variables indicate no multicollinearity 
because all correlations are < .7 (see Table 6). An analysis of standardized residuals showed that 
the data contained no outliers (Minimum = -2.068, Maximum = 2.034) with values between -3 to 
3. The histogram of the standardized residuals indicated a non-normal data distribution with 
points that were not completely on the line but close. Tabachnick and Fidell (2018) state that 
multivariate outliers exert undue influence on a regression if Cook's distance is larger than 1.0.  
Cooks distance for this sample showed no values > 1 (.000 - .239). Therefore, the next step was 

























PHS - -.066 -.070 -.116 
Adherence to DMT -.066 - -.042 .010 
PRC -.070 .042 - .139 
NRC -.116 .010 .139 - 
  
Research Question 
Considered together, does Adherence to DMT and Religious Coping (PRC and NRC) 
explain a statistically significant portion of the Perceived Health Status (PHS) variance in 
patients diagnosed with MS?  
 Statistical regression analysis of PHS regressed on Adherence to DMT and PRC and 
NRC were done to determine the model fit (see Table 7). Considered together; the independent 
variables contribute no statistically significant variance to PHS (R2 = .02, p = .159). Examination 
of the Beta scores showed that NRC contributed the most to PHS (Beta = -.108, p = .087) but 
was not statistically significant. Likewise, PRC (Beta =.-.053, p = .404) and Adherence to DMT 
(Beta= -.062, p = .320) contributed very little to explained variance in PHS. Due to the low effect 
size (.02), the power to detect a statistically significant result at alpha .05 if it was present is only 









Table 7  
Predictors of Perceived Health Status 
Variable ß SE ß Beta T Sig. T 
Adherence to DMT -.935 .939 -.062 -.996 .320 
PRC -.186 .222 -.053 -.836 .404 
NRC -1.127 .657 -.108 11.716 .087 
 
F = 1.740 
 
Sig. F =.159 
 
Multiple R = .143 
 
R Square = .020 
 
Adjusted R Square = .009 
Note. N = 266. Analysis: Kendall-tau correlation coefficient. 
In conclusion, the present study proposed that Adherence to DMT, PRC, and NRC work 
together to predict PHS. The study results showed that these independent variables did not 
collectively contribute a statistically significant portion of PHS variance.  
Ancillary Analyses 
Perceived Health Status  
The standardized mean scores for PHS, PCS and MCS reported by the SF-36 scale 
developers (Hays et al., 1995) are (M = 50, SD = 10).  This sample’s PHS (M = 56.32, SD = 21), 
PCS (M = 50.81, SD = 24.71) and MCS (M = 61.84, SD = 22.88) means are higher than that of 
the reported standardized population. Therefore, comparisons between the standardized scores 
and this sample's data were made. One sample t-tests determined whether PHS, PCS, and MCS 
scores for this study were significantly different than the standardized population means. The 





population mean (t (4.6) = 6.32, p < .001) in PHS. Scores on PCS was not statistically 
significantly different (mean difference = .81) in scores (t (.524) = .81, p = .60) than the 
standardized population. However, MCS showed (mean difference = 8.26) statistically 
significantly higher (t (8.26) = 11.84, p < .001) scores than the standardized population score. 
Because this sample reported statistically significantly better  PHS than the standardized 
population, additional analyses were run to determine if this sample's self-rated health would 
also be significantly different from that reported for the national US health survey. 
The annual National Health Interview Survey (NHIS) is a multipurpose health survey 
administered by the Centers for Disease Control (CDC) National Center of Health Statistics 
(NCHS) to noninstitutionalized US adults 18 years and older (National Center for Health 
Statistics, 2019). Data are collected face to face or via computer-assisted interviews. The survey 
questionnaire, designed by NHIS, incorporates demographic, household, socioeconomic, and 
health topics deemed essential to US population health and emerging topics deemed critical to 
the NHIS. The questionnaire topics are based on public comments and expert opinions.  
As part of the questionnaire, NHIS uses the first question (see Appendix B) from the SF-
36 (Ware & Sherbourne,1992) to determine the population's self-rated general health. This one 
question is from a set of 21 questions that loads on the SF-36 PCS subscale to measure physical 
self-rated health. This self-rated one-question measure has been widely used and is a significant 
predictor of mortality and health care utilization (Idler & Benyamini, 1997; Imai et al., 2008) 
even when controlling for disability and other health conditions.   
Data from the NHIS indicate that 88.1% of the adult population 18 years and older in the 
US rated their health as good to excellent based on this single question. Therefore, to determine 





population using only the question used by the NHIS, one sample Chi-square analysis was 
conducted. With alpha set at .05, 72.5% of this study's participants self-rated their health on 
question one of the SF-36 as good to excellent. The rating was lower but not statistically 
significantly lower than the general population's 88.1% rating (2 = 13.87, df =24, p =.94). 
 Further analysis of the self-rated health question with the independent variables PRC, 
NRC, and Adherence to DMT (see Table 8) indicates people's self-rated health using the one 
question is statistically significantly inversely correlated with NRC (r = -.12, p < .01). Therefore, 
people reporting better self-rated health also report low NRC, and the reverse is true. As with the 
full PHS measure, there were no significant correlations between self-rated health and PRC (r = -
.02) or Adherence to DMT (r = -.06). 
Table 8  
Coefficient Self-rated Health With Independent Variables 
Variable Self-rated 
health 
PRC NRC Adherence to DMT 
Self-rated health - -.029 -.120* -.065 
PRC -.029 - .171** -.038 
NRC -.120* .171** - .093 
Adherence to DMT -.065 -.038 .093 - 
Note. ** p < 0.01, two-tailed. *p < .05, two-tailed.  
Analyses of Subscales. Analyses were then run to explore the effects of the independent 
variables (PRC, NRC, and Adherence to DMT) on the PHS subscales: PCS and MCS. 
Additionally, the relations between the components of the subscales (PCS/MCS and PRC/NRC) 
were explored. Because of the exploratory nature of the analysis, bivariate correlations (alpha 







 Correlation Coefficient Perceived Health Status, PCS, MCS, Adherence, PRC, NRC  




PCS - .658** -.054 -.059 -.007 
MCS .658** - -.065 -.069 -.212** 
Adherence to DMT .054 -.065 - .042 .010 
PRC -.059 -.069 .042 - .139* 
NRC -.007 -.212** .010 .139* - 
Note. ** p < 0.01, two-tailed. *p < .05, two-tailed. 
The expected strong positive correlation (see Table 9) between mental (MCS) and 
physical (PCS) health status perception was statistically significant (r = .65, p < .001).               
As respondents' perception of their physical health status went up, their mental health status   
also went up, and the opposite is true. Perception of Physical Health (PCS) did not      
significantly correlate with any of this study’s three independent variables: Adherence to DMT  
(r = -.05, p = .38), PRC (r = -.05, p =.34) nor NRC (r = -.00, p = .90). Also, perception of   
Mental Health (MCS) did not correlate with either Adherence to DMT (r = -.06, p = .29) nor 
PRC (r = -.06, p = .27). However, unlike the PCS, NRC was statistically significantly correlated 
to the MCS (r = -.21, p < .001). Therefore, as one's mental health status increased, then negative 
religious coping decreased. Finally, as previously reported by Pargament et al. (1998), in this 
study, the two components of the independent variable RC (NRC and PRC) were also 
statistically significantly positively correlated (r = .13, p = .001).  Hence, as either form of 
Religious Coping (NRC or PRC) increased, the other also increased. Because there are 
statistically significant results in the above correlations, further analyses were run to determine if 





Analyses of Type of MS on PHS. Independent samples t-test was conducted to compare 
PHS, PCS and MCS in relapsing and progressive MS. The results showed there was not a 
statistically significant difference in PHS scores for relapsing MS (M = 56.41, SD = 21.55) and 
progressive MS (M = 53.98, SD =7.03); (t (264) = .336, p = .73). Likewise, there were no 
statistically significant differences in scores for PCS in relapsing MS (M = 61.90, SD = 24.56), 
progressive MS (M = 47.81, SD = 8.98); (t (264) = .377, p = .70) or MCS in relapsing MS       
(M = 61.90, Sd = 22.77) and progressive MS (M= 60.15, SD = 5.07); (t (264) = .230, p =.81). 
Thus, the type of MS, relapsing or progressive did not influence PHS, PCS or MCS.  
Analyses Type of MS on Adherence to DMT and Religious Coping. Independent 
samples t-test was conducted to determine if the type of MS, relapsing or progressive influenced 
scores in Religious coping (PRC, NRC) or Adherence to DMT. There were no statistically 
significant differences in scores for PRC in relapsing MS (M = 12.37, SD = 6.12) and 
progressive MS (M = 11.87, SD = 1.45); (t (264) = .245, p =.80) or NRC in relapsing MS         
(M = 7.83, SD = 2.07) and progressive MS (7.73, SD = .27); (t (264) = .137, p =.89). In 
Adherence to DMT there was also no difference in scores with relapsing MS (M = .39, SD = 1.4) 
or progressive MS (M = .46, SD = .20); (t (264) = -.145, p = .88). These results also suggest that 
the type of MS reported by the participants has no effect on Adherence to DMT or Religious 
Coping. Given these t test results and low sample size (n = 36) in the progressive group, further 
analyses of the research question in the two groups using multiple regression was not done. 
Patterns of Response on Independent Variables   
When exploring the extreme positive skewness of both PRC and NRC, frequency data 





and (see Figure 2) 71.8% of respondents (n=191) had NRC scores of 7. Note, in Figure 3, that 
the mean scores for PRC are less than 13, and the mean scores for NRC are less than 8. 
Figure 1  















Figure 2  
















Figure 3  
Mean Positive Religious Coping and Negative Religious Coping Scores 
 
 
Likewise, Figure 4 shows that Adherence to DMT has severe positive skewness. 
Adherence to DMT also has very low variability, with approximately 78% (n = 208) participants 











Figure 4  
Adherence to DMT Scores and Frequencies 
 
PHS And Demographic Variables  
 Demographic data were analyzed in an exploratory regression analysis to determine 
which other independent variables may predict PHS variance. Studies on PHS in patients with 
MS indicate gender (Mavaddat et al., 2011), age (Krokavcova et al., 2012), employment for pay 
versus unemployed, income (Estrutti et al., 2019; Julian et al., 2008; Krokavcova et al., 2013), 
and marital status (Ren, 1997) are associated with better PHS. 
Because of the analysis' exploratory nature, bivariate correlations (alpha .05) were first 
run to investigate the relations between demographic variables and the dependent variable (PHS) 
as well as the components of PHS (PCS and MCS) (see Table 10). PHS was positively correlated 
with employment status (r = .32, p <.001) and income (r = .29, p < .001). As well, both PHS sub 





positively correlated with employment status. Income was also statistically significantly 
positively correlated with both sub scores: PCS (r = .29, p < .001) and MCS (r = .22, p < .001). 
Finally, as one’s age increased perception of PCS decreased (r = -.19, p < .001). Concerning the 
demographic variables’ intercorrelations, employment status was understandably positively 
correlated with income (r = .23, p < .001) and negatively correlated with age (r = - .11, p = .03) 
and income was negatively correlated with marital status (r = -.17, p < .001).  
Table 10  
Correlation Coefficient Perceived Health Status, MCS, PCS and Demographic Variables  




PHS - .903** .918** .081 -.079 .327** .291** .011 
MCS .903** - .658** .053 .058 .277** .226** .009 
PCS .918** .658** - .093 -.191** .315** .292** .005 
Gender .081 .053 .093 - -.083 -.029 .030 -.010 
Age -.079 .058 -.191** -.064 - -.112* -.050 .055 
Employment 
statusa 
.282** .204** .317** .090 .107* - .237** -.050 
Income a .291** .226** .292** .019 -.047 .237** - -.174** 
Marital 
statusa 
.011 .009 .005 .013 .064 -.050 -.174** - 
Note. * p < .05, two-tailed. ** p < 0.01, two-tailed. a Kendall's Tau. 
To account for shared variance, stepwise regression was then run due to the 
intercorrelations between employment and income, employment and age, income, and marital 
status. With alpha set at .05, PHS was regressed on employment, income, age, and marital status. 





significantly predicted PHS ( = 6.29, p < .001) contributing 18% of the variance. In step 2, 
income entered the equation and predicted a unique 6% PHS variance. Neither age nor marital 
status entered the equation. Together, employment and income predicted 24% of PHS variance, 
and employment is the primary predictor of overall PHS. Separate regressions were then run for 
both subscales (PCS and MCS). 
Table 11 
Regression Coefficients Perceived Health Status on Demographic Variables  






6.29** .82 7.60 .000 .18 57.87 .000 
2 Employment 
 
4.99** .84 5.9 .000    
 Income 3.45** .76 4.5 .000 .06 
 
  
Total      .24 20.31 .000 
Note. N = 266. ** p< .01. 
With alpha (.05), PCS was regressed on employment, income, age, and marital status. 
The results in Table 12 show three predictor models. In step 1, employment ( = 7.06, p < .001) 
alone predicts 18% of the variance in PCS. When income enters the equation (step 2), it 
contributes an additional 5% to the variance. Hence, employment and income considered 
together contribute 24% of the variance to PCS. Age entered the regression (step 3) and added a 
unique contribution of 1% to the variance for a total of 25%. Again, employment is the primary 









Table 12  
Regression Coefficient of PCS on Demographic Variables  




7.06** .94 7.48 .000 .18 56.02 .000 
2 Employment 
 
5.67** .96 5.81     
 Income 
 
3.81** .87 4.37 .000 .05   
Total 
 
     .23 18.98 .000 
3 Employment 
 
5.20 .97 5.32     
 Income 
 
3.94 .87 4.53     
 Age 
 
3.29 1.37 2.39 .017 .01   
Total      .25 5.73 .017 
Note. N = 266. ** p< .01. * p < .05. 
MCS was regressed on employment, income, age, and marital status. The results are 
shown in Table 13. Employment’s unique contribution to MCS ( = 5.52, p < .001) variance in 
step 1 of the regression is 13%. When income enters step 2, it contributes only an additional 4% 
to the variance. In step 3, age did enter the regression with a p-value approaching significance 
(.048) and only contributed another 1% to MCS variance. Again, employment emerges as the 
primary predictor of MCS. Employment status is the best predictor of PHS, MCS, and PCS in 
this sample. Although age and income had unique contributions to health status, they will not be 









Table 13  
Regression Coefficient of MCS on Demographic Variables  
Model Variable β SE ß T Sig. T R2  F Sig. F 
1 Employment 
 
5.51 .90 6.07 .000 .13 36.93 .000 
2 Employment 
 
4.35 .94 4.62 .00    
 Income 
 
3.08 .85 3.62 .000 .04   
Total      .16 13.10 .000 
3 Employment 
 
4.70 .95 4.94 .000    
 Income 
 
2.98 .84 3.51 .001    
 Age 2.66 1.34 1.98 .048 .01   
Total      .17 3.95 .04 
Note. N = 266. ** p< .01. 
  With MS, older age (> 55 years old) is associated with a greater probability of disability 
(Trojano et al., 2002) with worse PCS (Wilski & Tasiemski, 2016).  Therefore, the longer one is 
diagnosed with MS, the disability to some degree is more likely to occur. Additionally, in this 
study, age's contribution to PHS, PCS, and MCS variance was minor. Therefore, age will not be 
included in the final analysis.  
Low socioeconomic status and income ranges at or near the poverty level can lead to 
poor health (Stronks et al., 1997; Woolf et al., 2015). However, people with disabilities are more 
likely to earn less and work fewer hours and often supplement income with disability benefits 
(Walls & Dowler, 2015) and may not report poor PHS.  Importantly, to adequately consider 
income, a comprehensive household size analysis, all other revenue, how much is available for 
the participant's use combined with employment status cannot be determined. Therefore, income 





PHS, PCS, and MCS, one-way ANOVAs were done with follow-up post hoc tests to determine 
employment group differences. 
The ANOVA for PHS yielded overall statistically significant (F (4,250) = 19.07, p < .001) 
variations among the groups. Pairwise comparisons among the employment conditions (unable to 
work, unemployed, retired, work part-time, and work full time) were conducted using Tukey's 
HSD. Based on Tukey's results (see Table 14), there are significant mean differences among the 
groups. The mean difference in PHS scores for people who are unable to work (M = 40.09, SD 
=14.79) compared to all employment groups is statistically significantly lower than: unemployed 
(mean difference = -24.76, p < .001), retired (mean difference = -15.35, p < .001), employed 
part-time (mean difference = -25.23, p < .001) and employed full time (mean difference =- 27.18, 
p < .001). Most notably, PHS scores of those unable to work are statistically significantly lower 
than all other groups. Regarding differences amongst the remaining work categories, retired 
responders had lower PHS scores than those working full time (mean difference = -11.83, p = 
.002). Interestingly, the PHS scores of those who reported that they were not working instead of 













Table 14  
Between Subjects Comparisons for Employment and PHS 
Employment Employment Mean difference SE Sig. 
Unable to work Unemployed -24.76* 4.90 .000 
Retired -15.35* 3.18 .000 
Work part time -25.23* 4.90 .000 
Work full time -24.76* 4.90 .000 
Unemployed Unable to work 24.76* 4.90 .000 
Retired 9.41 4.75 .279 
Work part time -.46 6.04 1.000 
Work full time -2.42 4.86 .988 
Retired Unable to work 15.35* 3.18 .000 
Unemployed -9.41 4.75 .279 
Work part time -9.88 4.75 .233 
Work full time -11.83* 3.11 .002 
Work part-time Unable to work 25.23* 4.90 .000 
Unemployed .46 6.04 1.000 
Retired 9.88 4.75 .233 
Work full time -1.95 4.86 .995 
Work full time Unable to work 27.18* 3.34 .000 
Unemployed 2.42 4.86 .988 
Retired 11.83* 3.11 .002 
Work part time 1.95 4.86 .995 
Note. * The mean difference is significant at p < .05. 
As in overall PHS, one-way ANOVA results for employment differences in PCS  
sub scores (F (4,250) = 21.76, p < .001) show that there were overall group differences (see 
Table 15). Again, pairwise results show that the mean scores for people who are unable to work         





(mean difference = - 31.13, p < .001), retired (mean difference = - 12.26, p < = .00), employed 
part time (mean difference = - 28.63, p < .001), and employed full time (mean difference = - 
30.97, p < .001). As with overall PHS scores, people who report being unable to work have the 
worst PCS of all employment conditions. 
For retirees, whose overall PHS scores showed statistically significant lower scores only 
than those of full-timers, their PCS sub scores were quite remarkably different. Retirees’ scores 
on the physical component (PCS) showed statistically significantly lower scores than the 
unemployed (mean difference = -18.86, p = .004), part-timers (mean difference = -16.36, p = .02) 
and full-timers (mean diff = 18.70, p < .001). These findings show that people who are unable to 
work are significantly worse in PCS than all other employment groups. Those who are retired 
rate their PCS higher than only those reporting they are unable to work. Notably, again PCS 
scores of those who are unemployed instead of being unable to work are quite comparable to 
















Table 15  
Between Subjects Comparisons for Employment and PCS   
Employment Employment Mean difference SE Sig. 
Unable to work Unemployed -31.13* 5.50 .000 
Retired -12.26* 3.57 .006 
Work part time -28.63* 5.501 .000 
Work full time -30.97* 3.75 .000 
Unemployed Unable to work 31.13* 5.50 .000 
Retired 18.86* 5.33 .004 
Work part time 2.50 6.78 .996 
Work full time .16 5.45 1.000 
Retired Unable to work 12.26* 3.578 .006 
Unemployed -18.86* 5.33 .004 
Work part time -16.36* 5.33 .020 
Work full time -18.70* 3.50 .000 
Work part-time Unable to work 28.63* 5.50 .000 
Unemployed -2.50 6.78 .996 
Retired 16.36* 5.33 .020 
Work full time -2.34 5.45 .993 
Work full time Unable to work 30.97* 3.75 .000 
Unemployed -.16 5.45 1.000 
Retired 18.70* 3.50 .000 
Work part time 2.34 5.45 .993 
Note. * The mean difference is significant at p < .05. 
The final ANOVA concerning employment differences was done with MCS scores. 
Again, one way ANOVA yielded significant MCS differences (F (4,250) = 11.77, p < .001) 
among the employment groups. Consistent with the above findings, a post hoc Tukey test (see 





significantly lower (M = 46.37, SD = 19.87) than all other groups: unemployed (mean difference 
= - 18.40, p = .00 ), retired (mean difference = - 18.43, p < .001), employed part-time (mean 
difference = - 21.84, p = .00 ), and employed full time (mean difference = - 23.40, p < .001 ).  
Interestingly, unlike with PCS, in MCS there were no significant differences between being 

























Table 16  
Between Subjects Comparisons for Employment and MCS  
Employment Employment Mean difference SE Sig. 
Unable to work Unemployed -18.40* 5.43 .007 
Retired -18.43* 3.52 .000 
Work part time -21.84* 5.43 .001 
Work full time -23.40* 3.70 .000 
Unemployed Unable to work 18.40* 5.43 .007 
 Retired -.03 5.26 1.000 
 Work part time -3.44 6.69 .986 
 Work full time -5.00 5.38 .885 
Retired Unable to work 18.43* 3.52 .000 
 Unemployed .03 5.26 1.000 
 Work part time -3.40 5.26 .967 
 Work full time -4.96 3.45 .603 
Work part-time Unable to work 21.84* 5.43 .001 
 Unemployed 3.44 6.69 .986 
 Retired 3.40 5.26 .967 
 Work full time -1.56 5.38 .998 
Work full time Unable to work 23.40* 3.70 .000 
 Unemployed 5.00 5.38 .885 
 Retired 4.96 3.45 .603 
Note. * The mean difference is significant at p < .05. 
Interestingly, the mean scores of the unemployed align with the people who work. 
Although a small (n =20) 7% of the sample, knowing who the unemployed are may indicate why 
they align with the employed. 
The unemployed (n = 20) are between 35 and 64 years (65%) and primarily female (n = 





(n = 15), report their marital status as separated. With 85% (n = 17) reporting incomes greater 
than $35,000, and 55% (n = 11) with incomes over $100,000. Additionally, 2 had some college 
credit, with the majority (n = 18) having a college degree. This group is educated, primarily 
female, below the US full retirement age with high reported income.  
Concerning the subsample of people who are unable to work (n = 63), they are primarily 
female (n = 55), with 93% (n = 59) in the 35 to 64 age range. A large 58.7% reported marital 
status as separated. Most have a college education 68.3% (n = 43). This sample is educated, and 
most participants are below the 2019 full US retirement age of 66 years (SSA.gov, n.d.). Reported 
income for this group ranged from less than $20,000 to over $100,000. Furthermore, most         
(n = 50) reported having relapsing rather than progressive MS. Progressive MS tends to have a 
higher and more profound disability trajectory that can lead to the inability to work and job     
loss (Julian et al., 2008).  This group also reported lower MCS than all other employment groups.  
The MCS has shown significant negative correlation (r = -.21, p < .001) to NRC for this study. 
However, the unable to work group’s NRC scores (M = 7.9, SD = 1.9) are not  
significantly different from the other study population scores (M = 7.8, SD = 2.12) on 
 NRC (t (190) = .007, p = .99).  
Retirees (n = 90) are older than people who are unable to work, ranging in age from 45 to 
over 75 years. Notably, most (n = 81) are older than 55 years with (n = 50) 79.4% reported 
having relapsing MS. A considerable number have a college degree 74.4% (n = 60), with 66.7% 
(n = 61) reported earnings greater than $35,000. Most of these retirees reported being separated 
68.9% (n = 62). Compared to people unable to work, these retirees are older with higher reported 
income. Both groups of people who are unable to work and retired are primarily separated with 





People who are unable to work are significantly different from people in the other 
employment conditions, with scores lying at the lower end of overall PHS and each component 
score: PCS and MCS. Retirees have lower PCS scores than the unemployed, part-timers, and 
full-timers but have similar MCS scores to these groups. Those who are unemployed (rather than 
unable to work) have remarkably similar overall good PHS, PCS, and MCS to those working 
part-time and full time and have higher PHS, PCS, and MCS scores than those who are unable to 
work and retired. 
Summary of Results 
 In this study of people with MS, three variables were examined: PHS, Adherence to 
DMT, and Religious coping. Collectively, neither Adherence to DMT or Religious Coping was 
significantly correlated with PHS. Participants showed little evidence of religious coping 
measured in this study with uniformly low scores in both PRC and NRC. Likewise, most 
participants reported 100% Adherence to DMT. 
However, in ancillary analyses, significant findings were found that require continued 
discussion. Employment status was the best predictor of overall PHS, Physical and Mental 
health. People who were unable to work had lower overall PHS, Physical, and Mental health than 
all other employment groups. Retirees had lower overall PHS and Physical health than other 
employment groups with better Mental health than people unable to work, similar to all other 
employment groups. Negative Religious Coping was significantly negatively correlated to age 
and Mental Health. Additionally, this sample's PHS, Physical and Mental health was significantly 
better than the standardized population's mean, and the study participants' self-rated health was 







The purpose of this study was threefold: the first was to examine the relations among 
Perceived Health Status (PHS), Adherence to DMT (Disease Modifying Therapy), and both 
positive and negative Religious Coping (PRC and NRC) in adults with MS to further develop the 
concept of reconstitution in the Neuman Systems Model (NSM) (Neuman and Fawcett, 2011).  
In particular, the study examined the impact of the physiological and spiritual lines of resistance 
on reconstitution to the normal line of defense. The second purpose was to examine these NSM 
concepts at a theoretical level. A literature review suggested that problem-focused (Adherence to 
DMT) and emotion-focused (Religious Coping) coping can heighten PHS. If successful 
adaptation occurs, there is reconstitution to a new normal evidenced by high PHS. Lastly, the 
study proposed to test these theoretical links empirically by measuring the dependent variable 
PHS using the SF-36 (Ware & Sherbourne, 1992), the independent variables Adherence to DMT 
with the MS-TAQ (Wicks et al., 2011), and Religious Coping with the Brief-RCOPE (Pargament 
et al., 2011). Appendix A illustrates the conceptual, theoretical, and empirical (C-T-E) links. 
As noted earlier, neither Adherence to DMT nor Religious Coping influenced PHS in this 
sample. The only statistically significant findings surfaced in ancillary analyses concerning the 
effects of work status on PHS. This discussion explores this study's findings at all three levels: 
empirical, theoretical, and conceptual. The operationalization of the study variables is discussed 
first in the empirical referent section. Discussion of the research question results, and ancillary 
findings follow in the theoretical referent section. Finally, a discussion of the study’s findings on 





Empirical Indicators  
RAND 36-Item Short Form Survey (SF-36) 
The SF-36 (Ware & Sherbourne, 1992)  measured PHS (see Appendix B).  The SF-36 is a 
36 item 100-point questionnaire comprised of two summary scales that measure Physical and 
Mental Health. Scores on each scale range from 0 to 100. The scales are averaged to obtain an 
overall PHS score. High scores indicate good to excellent PHS, Physical Health, and Mental 
Health. The SF-36 is the most widely used measure of health-related quality of life in the US 
(Jenkinson et al., 1994; Lins & Carvalho, 2016; McHorney et al., 1993; Pittock et al., 2004).  
The standardization of the SF-36 as a self-report measure of functional health and well-being 
used factor scoring coefficients from the general US (N = 3,445) population to arrive at 
standardized population scores (M = 50, SD = 10) (Ware et al., 1995) for overall PHS, as well as 
both Physical and Mental Health subscale scores. In this study, PHS scores ranged from 6.13 to 
94.15 (M = 56.32, SD = 21.67). This sample's higher SD (21.67) compared with the population 
SD (10) is likely indicative of the varying functional disability of this study's participants.  
Notably, people with MS exhibit wide variations in disability.     
Fisher's measures of normality showed that PHS scores were not skewed (.046) and had a 
slight but statistically significant negative kurtosis (- 3.52). Thus, the non-normality of the 
dependent variable did not account for this study's non statistically significant findings. 
Regarding the PHS subscales: Physical scores (M = 50.81, SD =24.71) were not skewed (.928) 
but had a statistically significant kurtosis (- 4.16) and Mental scores (M = 61.84, SD = 22.88) 
had statistically significant negative skew (-2.56) and kurtosis (-3.16). These were notably mild 
deviations from normality. Again, note the high SD’s for each subscale in comparison to the 





score was .75. All are comparable to reported reliability estimates in other MS studies using the 
SF-36 (McHorney et al., 1993; Riazi et al., 2003; Szilasiova et al., 2011).   
Compared to the standardized population means (M = 50, SD = 10) for overall PHS as 
well as Physical and Mental Health, this study’s sample (M = 56.32, SD = 21.67) had statistically 
significantly higher mean scores in PHS (mean difference = 6.3), (t (4.6) = 6.32, p < .001).  
Mean Mental Health (M = 61.84, SD = 22.88) scores were also statistically significantly higher 
than those of the population (mean difference = 8.26), (t (8.26) = 11.84, p < .001). However, 
surprisingly, mean scores on Physical Health (M = 50.81, SD =24.71) were not statistically 
significantly different (mean difference = .81) (t (.524) = .81, p = .60) than the standardized 
population. This last finding concerning the Physical Health score is notable because the 
standardized population mean reflects the general population and not solely people with 
disability such as MS, who would be expected to have worse physical health.   
One reason for this study's higher PHS and Mental Health means than the comparable 
population means likely stems from the necessary averaging of scores and the wide score 
dispersion. Physical Health scores ranged from 5.25 – 93.85, and Mental Health scores from        
7 – 96.50.  Mean scores are always sensitive to extreme values, but both subscales and the 
summary PHS must be averaged. Therefore, information was undoubtedly lost in the averaging 
process across such a large distribution of scores. The frequency distribution of Physical Health 
scores revealed no clusters concentrated around one score with the median (48.95). Likewise, 
Mental Health scores showed no clusters around one score with a median (65.37). 
Consequently, the summary scales may overestimate Physical and Mental Health in this 





Overestimation of the subscales would also lead to an overestimation of averaged PHS scores.  
Such overestimation introduces error variance and decreases the power of the statistical tests. 
MS-Treatment Adherence Questionnaire (MS-TAQ) V2 DMT-Barriers Subscale  
The MS-TAQ DMT-Barriers Subscale was used to measure Adherence to DMT (see 
Appendix D). This subscale independently quantifies Adherence to DMT and is reported to be a 
good predictor of missed doses (Wicks et al., 2011) because providers can assess adherence and 
patient-reported barriers to adherence.  In this study adherence ranged from 86 % to 100%, with 
78% of the participants reporting 100% adherence (non-adherence: M = .39, SD = 1.4). Unlike 
PHS, Adherence to DMT was not normally distributed. The data exhibited a statistically 
significant extreme positive skew (40.33) and kurtosis (148.79). No data entry errors were found 
that could account for non-normality, and missing data accounted for only 4.1% of MS-TAQ 
scores. Data transformation is sometimes recommended for failures of normality.  However, the 
assumptions of transformation indicate data must have no values of 0. There were (n = 208) 
78.2% scores of zero; therefore, data transformation could not be used to bring the data to a more 
normal distribution. Because good adherence was categorized as being ≥ 80% adherent, there 
may be a loss of information leading to the decreased statistical power. 
 The MS-TAQ has zero values; therefore, transforming the data may lead to erroneous 
results and underestimate adherence in this study. Such significant skewness and kurtosis of one 
variable can decrease the power of the statistical tests. Interestingly, few adherence studies report 
data distributions with skewness or kurtosis results. There may be a large percentage of values at 
0 or 100% because adherence is a continuous variable. Therefore, the distribution may be highly 





In MS, estimates indicate that only 30% to 40% of people adhere to medications (DMT 
Consensus MS Coalition, 2017), including all DMT's daily to once yearly dosing regimens. How 
adherence was calculated was not reported by the DMT Coalition and may be a factor in the low 
adherence rates. Additionally, the dosing reported by the DMT Coalition includes self-
administered and healthcare provider in center administered. Conversely, this study's inclusion 
criteria required self-administration only, and participants reported prescribed regimens from 
daily to monthly only.  
The different regimens may factor in the notably different adherence rates in this study 
than the DMT Coalition's report. Despite these differences, this study's adherence rates are 
similar to Kołtuniuk and Rosińczuk's (2018) adherence study.  In people with MS (N = 226), they 
found a 76.5% adherence rate calculated from the MS-TAQ barriers subscale. Though the 
authors did not report data skew or kurtosis results, they used the nonparametric Mann-Whitney 
U test to compare continuous variables. This may indicate a non-normal distribution.  
In a DMT adherence study, Devonshire et al. (2011) reported 75% of participants (N = 
2640) with  80% adherence to similar DMT dosing reported in this study. Likewise, Treadaway 
et al. (2009) reported 85% of participants (N = 708) were  80% adherent to DMT for 
medication regimens prescribed daily to monthly.  None of the mentioned studies reported data 
distribution: skew or kurtosis.   
Using patient self-reports for the past 28 days, Ožura, Kovac, and Sega's (2013) study 
with (N = 299) patients with MS found an 81.5% DMT adherence rate. They reported non-
normal data distribution but no report of skewness or kurtosis results.  Similarly, a multicenter 
study of adherence to DMT (N = 234) found a 86% adherence rate (Zwibel et al., 2011).  Zwibel 





kurtosis results. Because near-perfect adherence is a goal, regardless of how adherence is 
measured, there will be a risk of highly skewed data.  
Brief RCOPE   
The Brief Religious Coping (Brief RCOPE) scale (Pargament, Smith, Koenig, & Perez, 
1998) developed from Pargament's (1997) Theory of Religious Coping is a 14-item measure of 
positive (PRC) and negative (NRC) Religious Coping with life stressors.  This study is the first 
to use the Brief-RCOPE for patients with MS. 
The Brief RCOPE’s PRC and NRC scores range from a possible 7 (low) to 28 (high). In 
this study, scores ranged from 7 to 24 for PRC (M = 12.36, SD = 6.02) and 7 to 21 for NRC (M = 
7.83. SD =2.03).  Cronbach's alpha for the Brief RCOPE scales: PRC was .96, and NRC was .84. 
Cronbach's alpha for NRC is generally lower (.60 - .90) than PRC, as Pargament et al. (2011) 
reported. The PRC and NRC scales had a low positive correlation (r = .17, p = .001) which was 
also found in Pargament’s (1998) (r = .18, p < .001) correlational studies.  
Median scores were (median =12) for PRC and (median = 8) for NRC, indicating low 
levels of either type of Religious Coping for the study's participants. Roughly one-third (33.5%)  
(n = 89) of participants reported the lowest possible score (7) for PRC.  For NRC, the 
overwhelming majority (71.8%) (n = 191) reported the lowest possible score (7).  These low 
scores indicate a group that does not use Religious Coping methods or at least not Religious 
Coping as measured by the Brief RCOPE.   
Due to this preponderance of non-religious copers, Fisher's measures of skewness and 
kurtosis revealed non-normal distributions. PRC was significantly positively skewed (3.69) and 





severely positively kurtosed (23.15).  Though analyses were conducted with and without data 
transformations to correct non-normality, the results were the same. 
The PRC and NRC scales had a low positive correlation (r = .17, p = .001), and the few 
participants who did use Religious Coping reported using both positive and negative methods to 
cope. However, participants reported greater use of PRC (M = 12.36 SD = 6.02) and less NRC 
(M = 7.83, SD = 2.03). These results are similar to studies in medically ill patients (Freitas et al., 
2015; Tsevat et al., 2009; Vizehfar & Jaberi, 2017), who use more positive than negative 
methods.  However, this study's participants' mean, and median scores are low on both scales.  
A full factor analysis of the 14 items from the two subscales explored the scale's 
dimensionality (see full results in Appendix J), especially because this is the first use in       
MS participants. The analysis showed two factors present with Eigenvalues greater than 1 that 
explained 67.51% of the scale's variance. Additionally, like Pargament et al. (2011) results       
(2 =2406.46, df = 1133, p < .05), this study found significant (2 =2883, df =91, p < .001) 
Bartlett’s chi-square supporting the factorability of the matrix.  Similar to this study, in                 
a predominantly Christian sample, PCA of the Brief RCOPE also showed (2 = 604.89, df = 168, 
p < .001) significant Bartlett's chi-square, with a two-factor structure that together explained 
48.9% of the variance (Ramirez et al., 2012b). Additionally, Mohammadzadeh and Najafi 
(2016) explored the scale's factor structure with PCA on a Muslim sample and reported 
Bartlett's (p = .0001, 1911.3). They also found two distinct factors explaining 52.2% of 
observed variance, which is lower than the results obtained for this analysis. The evaluation of 
the psychometric properties of the Brief RCOPE shows reliability and construct validity 
replicating the results obtained in other studies. Therefore, the non significant study findings are 





Other considerations were explored to explain the lower means and medians in this 
sample compared to other studies using the Brief RCOPE.  One reason could be the wording of 
the questions in the scales.  For example, on the PRC, one question asked for 
agreement/disagreement with this statement:  
"Looked for a stronger connection with God." 
The response choices are: not at all (1), somewhat (2), a great deal (3), or quite a bit (4).  If 
participants are just not religious copers, they might rate that question and all the others (1), 
leading to low scores on the positive scale.  Consequently, a person will have only a minimum of 
7 on the positive scale because they just do not use religion to cope.   
Likewise, on the NRC, if the person is not questioning God's power or does not believe 
Religion has anything to do with illness, they may have low NRC and be identified as a low 
Negative religious coper.  Noted below is an example of an NRC question: 
"Wondered whether God had abandoned me."  
One can see that if religion were not a coping means, then that statement would likely be 
answered as not at all.  
Theoretical Elements 
Perceived Health Status In MS   
It was noted above that mean scores in PHS (M = 56.32, SD = 21.67) and Mental Health 
(M = 61.84, SD = 22.88) were higher in this sample than in the standardized (not exclusively 
MS) population (M = 50, SD = 10). Physical health mean scores were similar to the standardized 
population but had a higher SD (M = 50.81, SD = 24.71). The high dispersion of scores coupled 





from an empirical standpoint. From a theoretical perspective, studies in the MS population using 
the SF-36 were compared with the present study's data.   
Pittock et al., (2004) found markedly lower PHS (M = 39.2, SD = 12.7), Physical Health 
(M = 36.8, SD = 17.4) and Mental Health scores (M = 54.2, SD = 12.7) than those of the present 
sample, using only the SF-36 questions from the MSQOL survey. The MSQOL survey consists 
of the SF-36 with 18 additional items pertinent to MS. These 18 items were not used. Similarly, 
Szilasiova et al., (2011) (N = 114) found markedly lower Physical Health (M = 39.9, SD = 10.5) 
and Mental Health scores (M = 43.8, SD =11.1); overall PHS was not reported. Note also the 
lower SD's in both of these studies compared with the present study's very high SD's.  As in the 
present study, Mental Health scores in these studies are higher than Physical Health scores, 
indicating that people with MS report better mental than physical health. 
Reasons for the present study's higher overall and subscale means were considered. One 
noted empirical concern is the self-administration of the questionnaire in the present study. 
Specifically, Pittock et al. (2004) and Szilasiova et al. (2011) gathered the SF-36 questionnaire 
information from their study participants via interview and physical examination. Whereas, for 
this study, the SF-36 was self-administered online without the researcher's participation.   
Theoretical considerations may be related to the way people use cognitive appraisal 
processes to rate perceived health subjectively. Rapkin and Schwartz (2004, 2016) posited that 
any subjective appraisal process involves four appraisal aspects related to the person's frame of 
reference, sampling experience, comparison standards, and a combinatory algorithm to arrive at 
a summary judgment. These are necessary processes for people to understand and interpret the 





reappraisal are continually changing, reflecting positive or negative appraisal of illness based on 
its significance to personal well-being in the short or long term (Lazarus & Folkman, 1984). 
This study measured PHS within the past four weeks, capturing a cross-sectional measure 
of function and well-being. Perception could depend on the person rating themself against 
someone with MS, a specific MS symptom, or the overall meaning of well-being despite the 
illness. Thus, one’s perception involves subjective components and belief-laden variables. 
Notably, MS patients report feeling boxed into a diagnosis that implies poor outcomes when 
people with MS exhibit varied symptoms (Burtchell et al., 2019).  Albrecht and Devlieger (1999) 
proposed a "disability paradox" where people with significant disabilities are expected to 
perceive low health but instead rate health more highly than do people without disability.  This 
paradox suggests that ratings are subject to personal appraisal and may differ from how people 
without disabilities perceive health.  Self-rated health may not match objective medical 
assessments, and those assessments may give an incomplete picture of overall health (Drum et 
al., 2008).  
Life expectancy for people with MS is not significantly different from the general 
population, and people can live with MS for 20 – 55 years, depending on when diagnosed.  
Therefore, it is reasonable to expect people to cope and adapt to disability as they do with the 
normal aging process (Finlayson, 2004). This sample's characteristics reflect an aging MS group.  
The majority (n = 188), 70.7%, are over 55 years and likely were diagnosed more than 20 years 
ago.  Therefore, these participants are likely using highly individualized appraisal processes that 
were not measured or accounted for in this study.  Appraisal profiles may need to be a part of 
perceived health studies because they may be influencing factors that can quantitatively measure 





problems. These profiles may explain variance in perceived health because they may uncover the 
factors people think are essential in how they rate their quality of life.  
Another reason for the high means was clear in this study's ancillary analyses. 
Correlation of demographic variables; employment, income, age, and marital status with 
perceived health revealed employment status (r = .28, p < .001) and income (r = .29, p < .001) 
were significantly correlated with PHS. Stepwise regression showed employment status and 
income together explained 24% of the variance in PHS. 
However, of the total 24% explained variance, employment contributed a unique 18 %. 
Although income contributed 6% of variance to PHS, to include income as a predictor for this 
study, a comprehensive income analysis is needed to determine the household size, total 
revenues, and how much is available for the participant's use. Income, therefore, is not in the 
final analyses. ANOVA results showed that there were statistically significant differences in PHS 
(F (4,250) = 19.07, p < .001), Physical Health (F (4,250) = 21.76, p < .001) and Mental Health 
(F (4,250) = 11.77, p < .001) based on work status. Post hoc t-tests indicated scores for PHS (t 
(253) = 5.99, p < .001), Physical Health (t (253) = 6.8, p < .001), and Mental Health (t (253) = 
3.98, p < .001) were significantly lower for people who are unable to work compared with all 
other workgroups: unemployed, retired, or working part-time or full time. 
Their means were markedly lower than all other employment groups: PHS (M = 40.09, 
SD = 12.79), Physical Health (M = 33.82, SD = 16.17), and Mental Health (40.09, SD = 14.79). 
Participants who were unable to work (n = 63) made up nearly a quarter (23.7%) of the study's 
participants. This group was primarily female (n = 55), with 59 of the 63 participants being 
below the 2019 full retirement age of 66. This group reported being unable to work rather than 





MS. There are consistent associations between increasing disability, not working, and quality of 
life in MS (Busche et al., 2003; Krokavcova et al., 2013).   
The ability to keep employment is of concern to people with MS. Unemployment is more 
likely to occur when people exhibit disease severity markers that affect physical and cognitive 
function (Busche et al., 2003; Flensner et al., 2013; Julian et al., 2008).  Miller and Dishon 
(2006) found unemployment as a whole was associated with lower scores in overall PHS (Mean 
= 51.6, SD not reported) than for employed people (Mean = 64.6, SD not reported, p  .005) 
measured with the SF-36. These results align with this study’s results showing lower PHS in 
people not working than those employed. Additionally, like in this study, unemployed people 
rather than unable to work had scores not significantly different from the population (M = 50). 
Other demographic data in this study, age, gender, and marital status, were not 
significantly correlated with PHS. Age is notable because this sample is primarily (70.7%) older 
than 55 years (n = 188). In MS, older age (> 55 years) confers a greater probability of disability 
(Trojan et al., 2002) and worse physical health (Wilski & Tasiemski, 2016). This is because the 
age of MS onset is typically mid-twenties to thirties (Milo & Miller, 2014), and it is a 
progressive disease. The revised McDonald diagnostic criteria position paper (Etemadifar & 
Sabeti, 2018) for MS specifies three disease course types; primary progressive, relapsing and 
secondary progressive. The vast majority (85%) of people with MS are initially diagnosed with 
relapsing MS characterized by increasing central nervous system inflammation resulting in 
episodes of disability, with some symptom resolution after the inflammation subsides. Most 
people in this diagnostic grouping will transition to a progressive course marked by a gradual yet 





However, there are no definitive diagnostic markers for this transition from relapsing to 
secondary progressive beyond the absence of relapses. Because of the psychological impact of a 
secondary progressive diagnosis, health care providers are reluctant to make the actual change in 
diagnosis, and patients are reluctant to accept it if made (Ciotti & Cross, 2018).  Despite their age 
and thus likely longer time since MS diagnosis, 83% of participants over 55 years report having 
relapsing rather than secondary progressive (17%) MS and the Physical Health scores                
(M = 47.28, SD = 24.75) of those over 55 years of age are not significantly different            
(mean difference = - 2.71, p = .135) than standardized population scores (M = 50, SD = 10). This 
finding points to a differential appraisal process concerning health perception in this sample. 
Perceived Health Status And Adherence To DMT 
Good Adherence to DMT was proposed to be related to better PHS because of better 
reported clinical outcomes (Devonshire et al., 2011a; Treadaway et al., 2009). Participants in this 
study had to be on a DMT for a minimum of six months. Stopping DMT is more likely to occur 
in the first six months. Patients who continue therapy in the long term are more likely to have 
developed coping mechanisms to manage factors that might decrease adherence (Bruce et al., 
2010; Devonshire et al., 2011). In this study, over 78% of participants reported not missing a 
DMT dose in the past four weeks (100% adherence). The past four weeks appeared reasonable to 
be remembered by the participants about their drug regimen. Missing a single dose was a 
stringent criterion, but pre-defined criteria were necessary as a benchmark because of the varied 
dosing regimens and reports in the literature. Adherence was measured as a binary static 
construct. Either one is adherent or is not.  
Though participants were adherent, they were within the reported adherence studies rates, 





et al., 2011), there was no statistically significant relationship between Adherence to DMT and 
PHS in this sample. The empirical measure of adherence with highly skewed data discussed 
previously may have contributed to the non-significant findings. Also, the questionnaire elicits a 
self-report of adherence. Self-reports are controversial, but there is support due to theoretical and 
empirically sound adherence measures (DiMatteo et al., 2002; Nguyen et al., 2014; Svarstad et 
al., 1999). This study did not gather adherence data from chart review, pharmacy refill data, or 
pill counts due to the anonymous design.  
Participant demographics could account for the adherence rates and highly skewed data. 
There are inconsistent reports of which demographic influence (gender or age) is of primary 
importance in adherence.  Being female and older than 34 years (Devonshire et al., 2011a; 
Treadaway et al., 2009) confers greater odds of better adherence than males or younger than 34 
years. This sample was primarily female (n = 217) 81.6% and 94.4% were older than 34 years of 
age.  Zhornitsky et al. (2015) reported people younger than 18 – 30 years were 7.8 times more 
likely to stop DMT and be less adherent than people who were 31 and older.  In the present 
study, only two participants were younger than 24 years, and two participants were 25 – 34 
years.  Since most, 93.2% (n = 251) of the participants were older than 34; this may also 
contribute to the high adherence rates noted in this study.  
Additionally, the knowledge that DMTs could decrease relapse rate, decrease CNS 
damage, and slow disease progression may influence adherence (Bruce et al., 2010; Coyle et al., 
2014). Therefore, MS type may influence adherence, particularly because DMTs for relapsing 
MS have shown effectiveness. People who believe they have relapsing MS may be more    





providers who prescribe DMTs is to help patients see the benefit of their long-term use in 
slowing disease progression.   
The first DMT was FDA approved in 1993 for relapsing MS, and they have become 
increasingly efficacious in recent years. Until 2017, DMTs were primarily effective in relapsing 
MS with limited secondary progressive MS efficacy (Maskaly, 2018). Since that time, one DMT 
has shown effectiveness in primary progressive MS, and others are in development. Thus DMTs 
have a long history of treating relapsing forms of MS and limited availability and efficacy in 
secondary progressive MS. Most participants (n = 230) 86.5% in this study reported having 
relapsing MS and may be more hopeful of DMT benefits and be more adherent.   
It is reasonable to think that participants who believe medications are helping may rate 
PHS better—giving support to the value of appraisal profiles. Treadaway et al. (2009) reported 
similar results to the present study. Adherent people recruited from 17 neurology clinics had 
significantly higher scores on both Physical Health (M = 59.7, SD = 20.7) p = .0020 and Mental 
health (M = 69.5, SD =20.5) p = .0001(t not reported) health, than non adherent people. The high 
adherence rates coupled with high Physical (M = 50.81, SD =24.71) and Mental (M = 61.84, SD 
= 22.88) scores reported for the present study may indicate a highly adherent sample that is 
representative of participants enrolled in NARCOMS. These people may be more apt to enroll in 
studies that measure adherence. Turner et al. (2007) also reported better than 80% adherence in 
people who perceive beneficial DMT outcomes. Adherence may be related to personal appraisal, 
attitudes, beliefs, and self-care and may not function singularly as a coping mechanism. If so, 
then perceived health ratings might be independent of how adherent people are. 
Finally, it is important to consider that there may be no correlation between Adherence to 





adhering does not influence perceived health. Specifically, as detailed above, given the typical 
age at onset of MS, higher age is associated with a longer duration of having MS. A longer 
duration of having MS is associated with the transition to secondary progressive MS (Burtchell 
et al., 2019). Thus there are two effectiveness-related explanations for the lack of association 
between Adherence to DMT and PHS.  The first explanation centers on the fact that DMT's are 
effective when used early in the disease and regularly throughout the disease (Ben-Zacharia, 
2011). Given recent advances in the effectiveness of MS DMTs, the older age of this sample, and 
their probable age at diagnosis, it is highly likely that most of them did not have access to 
effective DMTs for an extended period after being first diagnosed. Thus, their MS was left 
untreated for many years, and prompt treatment with DMTs shows the best results.  Thus no 
correlation between current DMT adherence and PHS.   
The second explanation is somewhat related. Previously noted, there is hesitancy on  both 
providers and patients to transition to the secondary progressive diagnosis. This hesitancy has 
psychological and practical roots. Most of the DMTs in use today have limited efficacy in 
secondary progressive MS (Maskaly, 2018). So those with secondary progressive MS but 
identifying as relapsing are likely taking a DMT that is not effective. It follows then that 
Adherence to DMT and PHS are working independently. It would be beneficial to restrict the age 
to younger participants or specify disease duration less than ten years in future studies to account 
for advances in DMT science and disease progression. 
Perceived Health Status And Religious Coping 
 Positive and Negative Religious Coping was theorized to work with DMT adherence to 
help people manage MS's stress and improve PHS. In this study, with the lowest level being 7, 





SD = 2.03). To manage stressful situations, religion can be a source of strength. Pargament et al. 
(2000) reported that PRC and NRC are differentially related to physical and mental health, and 
higher NRC is associated with worse physical and mental health.  
This study's main findings indicate that, considered together with Adherence to DMT's, 
neither PRC (Beta =.-.053, p = .404) nor NRC (Beta = -.108, p = .087) contributed to explained 
variance in PHS. In ancillary analyses, it was found that PRC was not associated with Physical 
Health (r = .05, p = 34) nor Mental Health (r = -.06, p = .29). Additionally, no associations 
between NRC and Physical Health (r = .00, p = .90) were found. However, high use of NRC was 
associated with worse Mental Health (r = -.21, p < .001), indicating the differing impact on 
mental health as proposed by Pargament and colleagues (2000).  
These ancillary findings concerning PRC are contrary to reports from Sherman et al. 
(2005) indicating significant correlations between PRC and both Physical Health (r = -.18, p < 
.01) and Mental Health (r = - .29, p < .01). Sherman et al. measured PHS using the SF-12, a 
similar but shorter version of the SF-36 in participants (N = 213) with multiple myeloma. 
However, similar to this study, Sherman and colleagues report that people who reported high 
Mental Health scores also reported low NRC (r = -.29, p < .0001), showing that low NRC is an 
indicator of psychological well-being.  
Similarly, in a sample  (N = 170) of dialysis patients, Ramirez et al. (2012) used the Brief 
RCOPE and the WHO HRQoL (WHO, n.d.) to measure quality of life and found Mental Health 
(r = -.26, p < .01) negatively correlated with NRC. Conversely, PRC was correlated to better 
quality of life (r = .17, p = .02) and Mental Health (r = .26, p < .01). However, there were no 





overall indicator of poor mental health for the present study's participants. Analysis of the non-
significant main findings for PRC and NRC and overall PHS in this study were then investigated. 
Consideration was given to the question wording on the scales. Participants' answers to 
the scale's questions, coupled with 17.7% (n = 47) of the participants identifying as 
agnostic/atheist, may have contributed to low Religious Coping scores and non-significant 
findings in this study.  Possibly, low Religious Coping may not be disadvantageous for people 
with low religiosity, hence the high (M = 56.32, SD = 21.67) PHS scores despite low Religious 
Coping scores.  If people do not view religion as essential to their lives, Religious Coping 
methods will not factor into how they cope with stressors.  
However, further analysis of the scales' dimensionality was necessary to determine if 
ambiguous factor loadings explained why most participants had low PRC and NRC scores. 
Because the Brief RCOPE is the most widely used measure of Religious Coping, PCA provided 
additional information on the scale’s dimensionality. As reported above, the psychometric 
properties are satisfactory for use in people with MS, replicating results obtained by Pargament 
et al. (2011) and other authors. Therefore, the reliability and construct validity of the instrument 
was not a factor in the non-significant findings.  
Theoretically, there may have been some confusion about Religious Coping and how 
people use it based on a personal appraisal of its significance in their lives. The literature defines 
spirituality broadly and includes personal experience, public expressions, and religion (Wirth & 
Büssing, 2016; Zwingmann et al., 2011).  Additionally, there are definitional incongruences 
among the authors.  
Religion/religiosity could be a formalized set of principles practiced by an individual 





religiosity and religiousness. In contrast, other authors consider spirituality and religion as 
overlapping dimensionally related constructs (Hill & Pargament, 2003). It is acknowledged that 
measuring spiritual coping in a religious context resulted from the researcher's personal and 
cultural bias and the varied definition noted in the literature.  
Participants' interpretation of Religious Coping may be related to religious attendance or 
congregational support, and they did not view religion as a primary coping mechanism. 
Conversely, people probably do not use Religious Coping to cope with all medical situations, 
particularly in a chronic disease where they may be more concerned with finding coping 
resources to manage other life-affecting disease changes. Because there were no studies in 
people with MS in the US, religious coping data from other chronic conditions such as 
inflammatory bowel disease (Freitas et al., 2015) and HIV (Lee et al., 2014) provided insight into 
how Religious Coping may be essential to cope with chronicity.  
Freitas et al. (2015) used the Brief RCOPE with the WHO Quality of life instrument with 
(N = 147) participants. They found more depression in study participants (β = 0.307, p < .001) 
with more significant NRC use. Thus, the link between NRC and Mental health surfaces again. 
Lee et al. utilized the more extended (63 items) version of the Brief RCOPE with the HIV/AIDS-
targeted quality of life instrument with (N = 198) participants. The results indicated that as NRC 
increased, there was a corresponding decrease in quality of life (r = -.39, p < .001). In these two 
chronic conditions, low NRC was important in psychological adjustment and supported the 
correlation with NRC and Mental health found in this study.  
If religion and spirituality are impactful in a person's life, they may be more apt to use 
religion to cope. Therefore, two explanations for the low levels of Religious Coping in this study 





to a higher power to cope with a disability. There may be an intrinsic reverence for religion that 
permeates throughout their lives but is not used as a primary coping mechanism. These 
participants may be secure in their chosen coping methods to manage MS, and those methods are 
working shown by the high scores in PHS.  
Additionally, people may use religion to cope when initially diagnosed. Mainly because 
there is no cure for MS; it is neurologically profound and is progressive over time. However, 
over time, people appraise the impact disability and chronicity of MS have on their lives and 
may need to solve MS's practical problems. Therefore, alternate coping mechanisms become 
primary to manage the consequences of MS, employment, and disability, that religion does not 
help solve.   
However, NRC was impactful in this study, and there are reports of the associations with 
mental health in the literature (Pargament, 1997, 2013; Pargament, 2002). Spiritual and religious 
well-being may be predictive of psychological adjustment to MS (Bussing et al., 2005; McNulty 
et al., 2004; Torskenæs et al., 2015). People may experience religious and spiritual struggles in 
life, and the struggles may lead to emotional distress and poor physical health (Exline et al., 
2014).  Therefore, Religious Coping may show significant correlations with health in those 
people. Notably, the PRC subscale assesses the supportive aspects of religion in times of 
adversity. However, if this sample did not connect with God or does not have religious or 
spiritual struggles, no insight would emerge from Religious Coping scores. Furthermore, no 
single measure has emerged as the gold standard (Hill & Pargament, 2003; Szaflarski et al., 






 The study's conceptual foundation based on the Neuman Systems Model (NSM) 
(Neuman & Fawcett, 2011) proposes that a person is an open and multidimensional system 
interacting with the environment. The individual's five-person variables: physiological, 
psychological, sociocultural, developmental, and spiritual, are inherent in all lines of defense and 
resistance and therefore affect the degree of protection against stressors. Pargament (1997) 
explicitly describes coping behaviors closely related to Neuman's spiritual variable in the lines of 
resistance. Spirituality is all-encompassing, affects all the other person variables, and offers 
protection against stressors.  
Neuman's (Neuman & Fawcett, 2011) and Pargament's (1997) propositions about the 
importance of the physiological and spiritual variables, and their effects on health outcomes, 
guided this study to examine their combined ability to return a person to system stability. MS is a 
stressor that invaded the normal line of defense and activated the lines of resistance. The person 
with MS would optimally adhere to DMTs and use Religious Coping to adjust and reconstitute. 
Reconstitution, a new normal, is rebuilding the normal defense line (Gehrling, 2011; Gehrling & 
Memmott, 2008). The normal defense line represented the state of wellness and adaptation of the 
individual to stressors over time. It was operationalized as PHS, which are health concepts that 
are real for and relevant to the patient. Two components make up PHS: Physical and Mental 
Health. The Normal Line of Defense, PHS, was measured with the SF-36 and represented a 
quantitative measure of Reconstitution.  
Perceived Health Status 
Analysis of PHS (M = 56.32, SD = 21) and Mental health (M =61.84, SD = 22.88) 





showing a high level of perceived wellness for the study participants. However, the differential 
stress of MS is clear in the large standard deviations of the participants' PHS (SD = 21), Physical 
Health (SD = 24.71), and Mental Health (SD = 22.88) compared to the general population       
(SD = 10).  The large SDs indicate that MS is widely variable (wide dispersion of scores) in its 
physical and mental effects on the system and can significantly influence Reconstitution. 
Consistent with the NSM's holistic view, the two summary scales of PHS were significantly 
positively correlated (r = .65, p < .001).  Therefore, as one's perception of Physical Health went 
up, Mental Health perception also went up. This correlation indicates Neuman's proposed 
interrelated effect of the lines of resistance in adapting to the stress of MS. The high PHS scores 
in this study provide evidence that Reconstitution is possible for people with MS. Additionally, 
the findings help expand knowledge of a quantitative measure of Reconstitution.  
Perceived Health Status And Adherence To DMT   
The physiological variable in the lines of resistance was proposed to be Adherence to 
DMT, a coping method used by the individual to help mitigate disease damage to the system. 
Adherence was quantified and measured with the MS-TAQ Barriers subscale. It was reasoned 
that as one is diagnosed with MS causing invasion of the normal lines of defense, the person 
appraises the situation and takes steps to minimize damage to the system by adhering to the 
medical regimen and taking the prescribed DMT. Adherence supports system stability by 
functioning as a defense mechanism to move the person back to a stable new normal 
(reconstitution). The majority, 78%, of participants reported high adherence at (86 % - 100%).  
Though there was a high level of adherence coupled with good mean PHS (M = 56.32), 
Physical Health (M = 50.81), and Mental Health (M = 61.84) scores, Adherence did not explain 





sample are more likely to have progressive disease, with greater physical and mental deficits. 
Therefore, adherence may not change the trajectory of the disease and thus not influence their 
perception of their physical or mental health.  
Perceived Health Status And Religious Coping   
In the NSM, the spiritual variable is an essential aspect of the system, and it permeates 
and interacts with all person variables. It was proposed to be Religious Coping because 
spirituality is a part of the human dimension; this aspect would assist in Reconstitution. The 
spiritual variable could help manage, provide comfort, and improve chronic health issues. 
Hughes et al. (2017) report that addressing religious and spiritual issues with patients will help 
with collaboration adjustment and coping. The spiritual variable can positively or negatively 
affect the interactions of the other variables. Coping strategies within the realm of spirituality are 
dynamic and help people manage environmental stressors that exceed personal resources 
(Lazarus & Folkman, 1984).  
A person’s spiritual energy may not become evident until a life event or crisis tests one’s 
belief in a higher power (Neuman & Fawcett, 2011). The person then incorporates spirituality 
into their lives. Spiritual energy helps one to achieve and sustain positive mental and physical 
outcomes. In a qualitative study, Bussing et al. (2013) report (N = 213) MS participants who 
identified being religious/spiritual did not find faith as a resource to cope but as a lifestyle to find 
gratitude and awe in living. Bussing et al.’s report is in line with the tenets of the NSM that the 
spirit controls the mind, which in turn is interconnected with the body. 
Study findings showed high use of NRC was significantly negatively (r = -.21, p < .001) 
correlated with Mental Health. Thus, high NRC inhibited Reconstitution. If the religious 





Mental Health reflects religion's negative effects in coping with MS. In people with HIV, positive 
religious copers had better odds (OR 1.07, 95% CI: 1.02 1.12, p = .008) of higher PHS and 
health outcomes after the HIV diagnosis (Lee et al., 2014) than did negative religious copers.  
Intrinsic use of positive Religious Coping helped manage the stress of HIV leading to better 
coping and adaptation.  Like this study’s results, Freitas et al. (2015) found greater use of 
negative Religious Coping was associated (ß = 0.196, p = .02) with worse Mental Health.  
Ancillary Findings 
Employment status was significantly correlated with PHS (r = .32, p < .001); Physical 
Health (r = .32, p < .001) and Mental Health (r = .27, p < .001). Regression analysis indicated 
employment status was the primary predictor (18% of variance) of PHS. In particular, being 
unable to work was significantly associated with worse PHS (M = 40.09, SD = 14.79), Physical 
Health (M = 33.82, SD = 16.17) and Mental Health (M = 46.37, SD = 19.87) than all other work 
groups in this study.   
Regrettably, disability status was not requested as demographic data, but unable to work 
is a good "stand-in" variable for disability. MS affects all dimensions of a person, and thus all 
person variables are affected. MS disability status is a good indicator of the strength of the Lines 
of Resistance to recover and Reconstitute. The physiological, psychological, sociocultural, 
developmental, and spiritual variables have a part to play in the ability of the Lines of Resistance 
to support Reconstitution (Neuman & Fawcett, 2011).  Therefore, all five-person variables are 
considered when discussing the impact being unable to work has on the participants' 
reconstitution effect. Gaining and keeping employment when diagnosed with MS depends on the 
disease progression and personal factors (Busche et al., 2003; Krokavcova et al., 2013; 





Physiological Variable   
The physiological variable refers to the body’s physical and physiological functions 
(Neuman & Fawcett, 2011).  There is a disruption in the physiological line of resistance with an 
MS diagnosis. The inability to work breached the line of resistance. This breach is evident 
because the Physical Health (M = 33.82, SD = 16.17) of the group was significantly lower than 
all other employment groups. Motl (2010) reports the neurodegenerative processes of MS will 
have a global effect on physical functioning due to increasing impairment, inactivity, and 
disability over time. Accumulating disability results in loss of employment, and the person 
cannot work due to the inability to perform role functions.  
Julian et al. (2008) report worsening of physical MS symptoms over a six-month 
timeframe confers greater odds (OR 1.41, CI 1.11 – 1.79, p < .01) of employment loss.  An 
involuntary reduction in income occurs, creating stress and consequently the lower PHS scores in 
people with MS who are unable to work in the present study. The effects of not working have 
been associated with greater psychosomatic symptoms and higher physiological stress reactions 
such as higher stress cortisol levels (Wong & Shobo, 2016).  McKee-Ryan et al. (2005) notes that 
negative physiological effects on the person who cannot work will also negatively affect 
psychological outcomes. This is congruent with Neuman’s proposed interrelated effects of the 
physical and psychological variables. 
Psychological Variable   
The psychological variable refers to internal and external mental processes and 
relationships (Neuman & Fawcett, 2011). In this study, people who are unable to work report 
statistically significantly lower Mental Health (M = 46, SD = 19.87) than all other employment 





the psychological consequences of MS, so with low Mental Health, Reconstitution is negatively 
affected. The low Mental Health scores show evidence of destabilization in the psychological 
lines of resistance. Unemployment, in particular an inability to work, produces high levels of 
psychological stress (Busche et al., 2003).   
The severity of depression with MS increases with more disabilities and has a negative 
effect on employment status (Forbes et al., 2006). The majority of participants, 93%, in the 
unable to workgroup were between 35 to 64 years old. Long term physical disease such as MS 
also contributes to more severe psychological distress in people younger than 65 compared to 
people > 65 years (χ2 = 8.15, df = 2, p = .017) (Goulia et al., 2012).  Most participants (58.7%) 
who are unable to work reported their marital status as separated, possibly leading to low social 
support and help from a partner to manage psychologically.  
Sociocultural Variable   
Neuman (2011) posits that the condition of the flexible lines of defense determines if 
stress can cause a stress reaction. The socio-cultural variable in the line of resistance relates to 
societal, cultural expectations and activities. People can live with MS for over 40 years, and 
many will not be economically able to support themselves because they are unable to work. The 
result is decreased earning power and economic productivity loss (Roessler et al., 2011).  Loss of 
income can negatively impact family relationships due to the loss of earning power and 
economic standing.  
Stronks et al. (1997) reported that financial loss from not working could mean losing 
hopes and dreams because it negatively impacts one's socioeconomic status. From a socio-
cultural aspect, it is evident that being unable to work is a stressor that plays an integral part in 





al.'s study reported they had more time to do things they have always wanted to do and found 
family relations were improved. The participants in that study showed there could be a state of 
balance and a path to Reconstitution based on appraisal and coping with the stress of not 
working.  
In a qualitative study on MS's economic impact, De Judicibus and McCabe (2007) 
reported that participants discussed a trade-off between unable to work and spending more time 
with the family. Therefore, the lines of resistance helped in the coping process to view the loss of 
employment as a way to reconnect with the essential people in their lives, appraising and 
changing the factors used to rate perceived health. Being unable to work due to MS may not 
change over a person's lifetime. Therefore, coping mechanisms are needed to adapt and to 
accommodate the new normal. 
Developmental Variable  
Many people are diagnosed with MS in early adulthood (Milo & Miller, 2014) when 
people typically consider plans to set up a career, confirm life paths, or have a family.  The 
developmental impact of being unable to work on the individual can be profound. Most of the 
people who are unable to work in this study are separated (58.7%). Participants (N = 100) in a 
pilot study with young adults (aged 18 – 31 years) from NARCOMS reported feeling 
embarrassed and worried about MS's personal effects on their lives and relationships (Buchanan 
et al., 2010). The worry was evident in their concerns for their future and how they would 
manage as the disease progresses. Due to the uncertainty of what the future brings, participants 
reported deferring life plans which affected personal relationships. Though most (68.3%) 
participants in this study who were unable to work had a college degree, being unable to work is 





Spiritual Variable  
Neuman (2011) indicates the spiritual variable must be considered when discussing the 
person. The spiritual variable permeates all system variables and is a search for life’s meaning. 
Neuman (2011) refers to spirituality as necessary for the functioning of the system. Measures of 
spirituality in this study were from a Religious Coping perspective. The people who were unable 
to work did not significantly differ from the other groups in Religious Coping.  
The NSM (2011) refers to the spiritual variable as “positive use of spiritual energy 
empowerment” (p17), not Religious Coping. Therefore, measuring spiritually quantitatively 
requires assessing the person’s awareness of spiritual energy, the definition of that energy force, 
and how the participants used spirituality to cope with changes in their condition. Stressors on 
the system catalyze positive spiritual thoughts and behaviors to affect the system through 
interactions with all variables. Only one aspect of the spiritual variable measured in this study 
correlated to Mental Health. People who reported low Mental Health had high NRC, but as 
noted, those who were unable to work did not use NRC more than other groups. Thus, it is clear 
that Religious Coping (PRC and NRC) was not used by the participants to cope with MS.  
Summary   
Participants were not able to work due to reduced physical and psychological health, as 
noted above. Working generally confers higher income than disability payments and, 
importantly, enables people to view themselves as independent rather than limited and dependent 
on others. Because of the disease's progressive nature, an involuntary reduction in income creates 
stress and negatively impacts people with MS. Being unable to work weakened all the lines of 
resistance. Conversely, those in all other work status groups gave evidence through high PHS 





that the system's reconstitution depends on the efficacy of the resistance lines (Neuman & 







Summary, Implications, Conclusion, and Limitations  
Overview 
 The aim of this cross-sectional randomized study of 266 people with MS was to examine 
the relations among the dependent variable, Perceived Health Status, and independent variables 
Adherence to DMT and Religious Coping. The  Neuman Systems Model's (Neuman & Fawcett, 
2011) conceptual underpinnings and Pargament's Theory of Religious Coping (Pargament, 1997) 
linked the variables. The research question aimed to determine if, considered together, does 
Adherence to DMT and Religious Coping explain statistically significant variance in Perceived 
Health Status? A self-administered web-based survey used the SF-36 (Ware & Sherbourne, 
1992), the MS-TAQ (Wicks et al., 2011), and the Brief RCOPE (Pargament et al., 2000). 
Questions from the BRFSS (CDC, 2018) described the participants' demographics. 
Summary Of The Findings 
 It was posited that Adherence to DMT and both Positive and Negative Religious Coping 
worked together to predict Perceived Health Status in people with MS. However, neither 
Adherence to DMT nor Religious Coping contributed statistically significant variance to 
Perceived Health Status. Participants' mean scores in Perceived Health Status were statistically 
significantly higher than the standardized population mean. Scores on the Mental Health 
subscale were also statistically significantly higher than the standardized population scores, and 
Physical Health scores were the same as the standardized population scores. Thus, participants 
perceived their health to be good despite having MS. Perceived Health Status' subscales (Mental 





Regarding the independent variables, there was very little variability in the scores.  
Participants were overwhelmingly Adherent to DMTs, and they had uniformly low Positive and 
Negative Religious Coping scores. It appears they did not use religion as a significant coping 
strategy. Additionally, Positive and Negative Religious Coping showed a small but statistically 
significant negative correlation. Finally, the only independent variable to correlate with any 
aspect of Perceived Health was Negative Religious Coping. Participants who used Negative 
Religious Coping had lower perceived Mental Health scores. 
In ancillary analyses, Employment Status contributed a statistically significant 18% of 
variance to Perceived Health Status. Participants who reported being unable to work had 
statistically significantly lower mean scores in overall Perceived Health, Physical Health, and 
Mental Health than all other employment groups. The unable to work group represented 
approximately 25% of the sample, and their scores were at the lower end of Perceived Health, 
Physical Health, and Mental Health. This group was primarily over 55 years old and likely had 
secondary progressive MS though most reported having relapsing-remitting MS.  
Implications  
Implications For Model Development 
 Fawcett and Gigliotti (2001) recommended researchers select a conceptual model to 
provide context and guide research. Therefore, this study was an essential first step into 
exploring Perceived Health Status as an indicator of Reconstitution to the normal line of defense 
in the NSM. The role of the Lines of Resistance in preventing a stress response is essential to 
help the system Reconstitute. The SF-36 (Ware & Sherbourne, 1992) quantified Reconstitution.  





quantitative measures of Reconstitution can vary depending on the aspect that is important to the 
researcher. 
The pros of viewing Reconstitution as a self-reported measure align with the system's 
multidimensionality discussed in the NSM. Items on the SF-36 aggregated Physical and Mental 
Health measures and the instrument's multidimensionality are evident in the sub-scores. Physical 
functioning, role limitations due to physical and emotional health, energy/fatigue, social 
functioning, pain, and general health comprise Perceived Health's aggregate score. However, 
measures of the spiritual and physiological lines of resistance were lacking. Therefore, the study 
analyses did not explain possible interrelations physiologically and spiritually. Regrettably, 
Religious Coping did not measure spirituality within the context of the NSM adequately. 
Although the study's results gleaned no key variable that positively affected 
Reconstitution, Employment Status, particularly being unable to work, taxed the system and 
contributed to the invasion of all resistance lines. All parts of the system are interrelated 
(Neuman & Fawcett, 2011); hence, examining any aspect of the NSM concepts requires the 
researcher to measure all interrelated variables in the Lines of Resistance. Conceptualizing and 
measuring Reconstitution requires consideration of disease factors with an account of their goals 
and expectations of their health.  
Implications For Nursing Practice 
Knowledge about how the Lines of Resistance work to defend the core can inform 
practicing nurses about the importance of nursing measures to support Reconstitution. Stressors 
affect all dimensions of a person's life with an MS diagnosis. Rehabilitation nurses are important 
to help patients rehabilitate successfully. The nurses are positioned to assess the physical and 





factors that influence the person's abilities to perform work-related tasks. Finally, collaborative 
interventions need to be planned to account for the patient's rehabilitative preferences. 
Rehabilitation services are important to intervene in physical and mental health issues 
affecting employment (Motl, 2010).  Considering the consequences of Employment Status on a 
person's quality of life, timely interventions at diagnosis for vocational rehabilitation may 
forestall eventual employment loss. Multi-professional interventions focused on improving and 
managing MS impairments are critical. Referrals for financial, rehabilitation and other support 
can facilitate Reconstitution for people with MS who are significantly affected by the disease 
(Gerhard et al., 2020).  Other psychological intervention methods may be necessary for people 
with MS who cannot work and try to cope with the profound physical, psychological, 
sociocultural, developmental, and spiritual impact of being unable to work.  
Implications For People With MS 
 People with MS face many uncertainties regarding disease course. The physical and 
psychological impact of MS can result in life-altering loss and lifestyle changes that affect the 
person and their loved ones. Employment challenges due to MS-related symptoms affect all 
aspects of a person's life. Work provides meaning in peoples' lives (Saunders & Nedelec, 2014), 
which can provide financial independence. However, more importantly, people with physical and 
cognitive disabilities identified that working is natural, a source of identity, and contributes to 
improved self-esteem and personal worth (Strong, 1998).   
Working can positively influence self-concept, self-efficacy, and self-reported health, 
empowering patients to communicate their concerns regarding when and if a return to work is 
possible. Outdated skills may impact a successful return to work. Therefore, people with MS 





and reliable multidimensional self-reported measures can help identify patient condition changes 
and communicate what is important to the individual to healthcare providers. Better 
communication can lead to more focused interventions.   
Implications For Healthcare Disparities 
Recent studies indicate that MS has a higher incidence in African Americans (10.2%) 
than Caucasians (6.9 %), Latinx Americans (2.9%), or Asian Americans (1.4%) (Khan et al., 
2015). Also, African Americans are at a 47% higher risk of developing MS than Caucasian 
Americans (Khan et al., 2015).  This study's racial demographic is skewed towards Caucasians. 
Caucasians made up 89.8% of the study participants; therefore, generalizability is limited to 
other groups.  
One recommendation for future research is to include more non-Caucasian participants to 
provide new MS insights (Institute of Medicine, 2001). Unemployment in African Americans is 
multifactorial and is compounded by MS. Older minority individuals with MS are less likely to 
be employed (Rumrill et al., 2015) than Caucasians. Potential barriers to study enrollment for 
racial and ethnic minorities are multifactorial; therefore, multilevel interventions to boost 
enrollment are needed (Hamel et al., 2016).   
The U. S. Department of Health and Human Services gives recommendations for age, 
racial, and ethnic diversity for clinical trial enrollment (FDA/CDER/Fox, 2019). Some of the 
recommendations can be adopted for social and behavioral science research. Underserved 
populations need better representation in research; therefore, targeted information and education 
may help them participate (Amorrortu et al., 2018). In this study, there was no consideration to 
capture information on nationality; therefore, sociocultural correlations of Perceived Health 







There is no debate on the fact that MS causes substantial physical and cognitive hardships 
to people, especially during the prime years of adulthood. Physical and cognitive disability 
affects all aspects of the person, and this was made evident by the fact that MS poses significant 
challenges to employment and its subsequent effect on Perceived Health Status. These challenges 
can affect how the person adapts to MS. Thus, Reconstitution is affected. The results of this 
study, though descriptive, call attention to the need to consider physical and cognitive disability 
to better understand Perceived Health Status in MS. However, the relationship between 
Perceived Health and disability is not straightforward. 
There is some support for the conceptual and theoretical link between Neuman's System 
Model (Neuman & Fawcett, 2011) and Pargament's Theory of Religious Coping (1997). 
Specifically, the effect of the spiritual line of resistance on Reconstitution to a new normal.  
The spiritual variable worked to weakly influence Reconstitution via negative Religious Coping. 
Participants who used less or no Negative Religious Coping reported better Mental Health.  
Perceived Health Status 
 Analyzing Perceived Health against demographic data showed Employment Status and, 
particularly, people who were unable to work had significantly worse Physical and Mental 
Health than all other employment groups. Perceived Health Status is an important measure of 
patients' condition and treatment outcomes and can help with collaborative care. MS can affect a 
person's daily life with disruption in social, family, and work functioning leading to diminished 





Examining the role of Employment Status in Perceived Health provided insight into the 
physical and mental effects MS has on those participants who were unable to work. The SF-36 
was a good measure of the participants' Physical and Mental Health and was a gauge of the 
disability status in the employment groups. Not expected were the overall high scores in 
Perceived Health for the study participants. More than 70% were older than 55 years, implying 
they lived with MS for years. People with MS typically have worse scores in Perceived Health 
than the general US non-MS population (Wilski & Tasiemski, 2016).  
The high scores in Perceived Health could indicate unique appraisal, and adaptational 
processes participants used to rate their PHS, particularly because of the long and progressive 
nature of MS. Because of the heterogeneous nature and variable presentations of the disease, 
how the patient views disease and its effects on their life are important. Therefore, addressing 
Perceived Health clinically involves a view of the total disease experience and not just a focus on 
disability. Perceived Health and disability may not be truly linear (Miller & Dishon, 2006), 
especially since one must adapt and learn to live with progressive disease.   
All aspects of one's life with MS are affected over time. To engage in adaptive coping, 
people are more likely over time to view their condition more favorably, resulting in decreased 
stress, adaptation, and higher Perceived Health Status (McCabe & McKern, 2002). Perceived 
Health's findings in this study show that many participants could adapt and reconstitute to a new 
normal living with MS. However, this Reconstitution was not related to Adherence to DMT nor 
Religious Coping in this study.   
Adherence to DMT 
 Adherence to DMT did not contribute significant variance to Reconstitution. Participants 





sample was participants from NARCOMS who enroll in studies that measure adherence. Mowry 
et al. (2009) reported better Adherence to DMT among older patients, and people who have good 
adherence may be more apt to enroll in studies that assess adherence. Studies have shown that, 
when approached, older adults are often willing to participate in research (Mody et al., 2008).  
Therefore, this study's data may favor the older MS population who probably have been adapting 
their lives to cope with MS for decades and truly arrive at a new normal, Neuman's normal line 
of defense. 
Adherence by itself was not an indicator of better or worse Perceived Health. There are 
most likely other potential mediators or moderators between Perceived Health and Adherence to 
DMT at play in the lives of this study's participants. Hofer, Choi, and Mase (2017) report 
satisfaction with information and knowledge about prescribed drugs led to better medication 
adherence.  This study's participants sampled from NARCOMS may likely be more 
knowledgeable about the types of DMTs, and the role DMTs can play in disability progression. 
These patients may be more similar in their beliefs about DMTs. Therefore, they had less 
variability in responses.   
There is value to research in using an organization to obtain an adequately powered 
representative sample size. With NARCOMS, many participants are willing to enroll in studies 
that benefit the MS community. Therefore, attracting respondents, decreasing time to data 
collection, and decreased recruitment cost for a sample is minimized. However, the respondents 
who are more willing to enroll may be more similar in beliefs and more adherent than 
participants recruited from a wide variety of settings. Future studies should employ systematic, 





community settings.  Other groups of patients may have less experience with research and bring 
a new perspective to the study, yielding significant findings generalizable to people with MS.  
How people with MS appraise the effect of DMTs on disease progression and beliefs 
about DMTs could have provided further insight on the role adherence plays in Perceived Health. 
People with MS are likely Adherent to DMTs with such serious side effects because of some 
inherent belief that disease trajectory will improve. The role of treatment belief as a predictor of 
Perceived Health Status requires further research.  
Religious Coping 
 The participants in this study were not religious copers, thus no explained variance in 
Perceived Health. Religious copers use religion to decrease stress and assist with problem-
solving techniques (Kossiwa et al., 2020).  Measuring Religious Coping as an independent 
variable did not provide insight into religiosity or spirituality in this study's sample. Though 
religiosity and spirituality can provide context to behavior, offer social support, a sense of 
meaning in life, and living a healthy lifestyle (VanderWeele et al., 2017), this cross-sectional 
design only showed weak associations between Negative Religious Coping and Mental Health.   
Religiosity/Spirituality measures may need to contain questions about the role religion 
plays in individuals' lives. How the person defines religion/spirituality, the importance it plays in 
their life, and not just how they use it to cope with illness requires further examination. 
Additional work is needed to conceptualize and operationalize the differences between religiosity 
and spirituality. The socio-cultural aspect is also important because the meaning of spirituality is 
diverse among different religious denominations, ethnic and cultural groups (Sessanna et al., 





variables, and people need to express their meaning of spirituality and define how it contributes 
to illness and health.  
Coping requires evaluating one's ability to manage stressful situations (Susan Folkman et 
al., 1986). Psychological factors are inherently important to people and influence coping with 
MS. Therefore, we need to understand the psychological variables that may determine MS-
related Perceived Health. Possibly, people with MS who appraise situations more positively 
show less emotion-focused coping. Adopting a more problem-focused task-oriented coping style 
to manage health problems may help solve practical issues living with MS. Quality of life and 
Perceived Health Status are more than just the sum of physical, mental, or disease diagnosis. All 
sources of life satisfaction, social support, self-efficacy, coping style, mood, and perceived 
support (Benito-León et al., 2003; Mitchell et al., 2005), as well as disease factors, may have 
been better predictors of Perceived Health Status in this study. 
Employment Status 
Being unable to work significantly affected all five-person variables. People with MS 
often cannot work because they typically are symptomatic with a progressive disease course 
(Bisht et al., 2014; Busche et al., 2003).  After diagnosis and the onset of symptoms, up to 80% 
of people with MS can become unemployed (Johnson et al., 2004).  However, work status in MS 
may be a dynamic process. People enter and exit the workforce for different reasons that may or 
may not be disease related. MS exacerbations that include mobility impairment, hand weakness 
or sensory loss, fatigue, and cognitive difficulties over six months were predictive of work loss 
in MS (Julian et al., 2008).  
One strength of this study is that Employment status was not defined as a dichotomous 





retired, working part-time or full-time, enabled more granular analyses of the participants in each 
group. What was lacking in this study was investigating the reasons why the person was not 
working. For example, being unable to work or unemployed may be due to having a permanent 
disability with no plans to re-enter the workforce. Conversely, a person may not be working due 
to temporary changes in life situations, possibly recovering from a relapse with plans to return to 
work, or reasons that are unrelated to MS. Women who are predominantly affected by MS are 
more likely to leave the workforce because of responsibilities not related to MS (Gerhard et al., 
2020). 
Furthermore, the Coronavirus (COVID) pandemic has changed the way Americans work 
(Parker et al., 2020).  Remote work may usher in a new paradigm for the workforce. People with 
MS-related disabilities may, if given a choice, keep working remotely. According to a new Pew 
Research Center Survey (2020), about 49% of workers felt they had more flexibility to choose 
the time of day to work leading to better role function. Of interest, the workplace COVID-related 
changes may allow people with MS to gain and keep their employment. Future studies should 
include qualitative descriptions of reasons for unemployment among patients with MS. 
Information about Employment Status before MS and current unemployment reasons are needed 
because non-MS factors also influence Employment status.  
Limitations 
Several limitations of the current study require attention. Most notable was categorizing 
the type of MS as only Relapsing or Progressive. Although there is no way to predict how a 
person's disease will progress, MS's subtypes have some differences in the disease trajectory.  
Identifying if participants had relapsing-remitting, secondary progressive, or primary progressive 





There are several considerations to discuss in light of this study's methodological 
limitations. This study was cross-sectional. Thus, it did not evaluate Perceived Health Status, 
Adherence to DMT, and Religious Coping (PRC and NRC) at different times along the 
continuum of MS and the patients' lives. MS is a progressive disease with accumulating physical 
and cognitive disability. Therefore, the adaptational processes that occur over a person's life 
contributing to Reconstitution were not captured in this study. There may have also been 
selection bias by using only participants from NARCOMS.   
The study variables Adherence to DMT and Religious Coping were key measures in the 
study. However, their importance in Reconstitution may have been hindered by not measuring 
current disability, specific types of MS, years since MS diagnosis, or appraisal methods used to 
arrive at Perceived Health Status. Despite these limitations, this is the first study to quantify 
Reconstitution and use the Brief RCOPE in people with MS. Research on Employment Status at 
all levels and its role in causing a stress reaction in all Lines of Resistance should focus on 
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SF-36 MS-TAQ Brief R-Cope SF-36 
Legend*:   
║= denotes moving from model concept to grand theory concept  
│= denotes moving from grand theory concept to theoretical linkages  
¦ = denotes moving from theoretical linkages to empirical indicators 
Gigliotti, E., & Minister, N. N. (2012) A Beginner’s Guide to Writing the Nursing Conceptual 






Terms and Conditions for Using the RAND 36-Item Short Form Survey (SF-36) 
RAND hereby grants permission to use RAND 36-Item Short-Form Health Survey in 
accordance with the following conditions, which shall be assumed by all to have been agreed to 
as a consequence of accepting and using this document: 
1. Changes to the Health Survey may be made without the written permission of RAND. 
However, all such changes shall be clearly identified as having been made by the 
recipient. 
2. The user of this Health Survey accepts full responsibility, and agrees to indemnify and 
hold RAND harmless, for the accuracy of any translations of the Health Survey into 
another language and for any errors, omissions, misinterpretations, or consequences 
thereof. 
3. The user of this Health Survey accepts full responsibility, and agrees to indemnify and 
hold RAND harmless, for any consequences resulting from the use of the Health Survey. 
4. The user of the 36-Item Health Survey will provide a credit line when printing and 
distributing this document acknowledging that it was developed at RAND as part of the 
Medical Outcomes Study. 








SF36 Health Survey. INSTRUCTIONS: This set of questions asks for your views 
about your health. This information will help keep track of how you feel and how well 
you are able to do your usual activities. Answer every question by marking the answer as 
indicated. If you are unsure about to answer a question, please give the best answer you 
can. 
1. In general, would you say your health is: (Please tick one box.) 
Excellent – 
Very Good – 
Good – 
Fair – 
Poor –  
2. Compared to one year ago, how would you rate your health in general now? (Please 
tick one box.) 
Much better than one year ago – 
Somewhat better now than one year ago – 
About the same as one year ago – 
Somewhat worse now than one year ago – 
Much worse now than one year ago –  
3. The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? If so, how much? (Please circle one 
number on each line.) 
    
Activities 







3(i) Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports 
1 2 3 
3(ii) Moderate activities, such as moving a 
table, pushing a vacuum cleaner, 
bowling, or playing golf 
1 2 3 
3(iii) Lifting or carrying groceries 1 2 3 
3(iv) Climbing several flights of stairs 1 2 3 
3(v) Climbing one flight of stairs 1 2 3 
3(vi) Bending, kneeling, or stooping 1 2 3 
3(vii) Walking more than a mile 1 2 3 
3(viii) Walking several blocks 1 2 3 
3(ix) Walking one block 1 2 3 
3(x) Bathing or dressing yourself 1 2 3 
4. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? (Please 
circle one number on each line.) 
  





4(i) Cut down on the amount of time you spent on work or 
other activities 
1 2 
4(ii) Accomplished less than you would like 1 2 
4(iii) Were limited in the kind of work or other activities 1 2 
4(iv) Had difficulty performing the work or other activities 
(for example, it took extra effort) 
1 2 
5. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional problems (such as 
feeling depressed or anxious)? 
  (Please circle one number on each line.) Yes No 
5(i) Cut down on the amount of time you spent on work or 
other activities 
1 2 
5(ii) Accomplished less than you would like 1 2 
5(iii) Didn’t do work or other activities as carefully as usual 1 2 
6. During the past 4 weeks, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbors, or groups? (Please tick one box.) 
Not at all – 
Slightly – 
Moderately – 
Quite a bit – 
Extremely –  
7. How much physical pain have you had during the past 4 weeks? (Please tick one 
box.) 
None – 




Very Severe –  
8. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? (Please tick one box.) 
Not at all – 
A little bit – 
Moderately – 
Quite a bit – 
Extremely –  
9. These questions are about how you feel and how things have been with you during 
the past 4 weeks. Please give the one answer that is closest to the way you have 
been feeling for each item. 
  (Please circle 
one number 










A little of the time None 
of the 
time 
9(i) Did you feel 
full of life? 





9(ii) Have you 
been a very 
nervous 
person? 
1 2 3 4 5 6 
9(iii) Have you 
felt so down 




1 2 3 4 5 6 




1 2 3 4 5 6 
9(v) Did you 
have a lot of 
energy? 
1 2 3 4 5 6 




1 2 3 4 5 6 
9(vii) Did you feel 
worn out? 
1 2 3 4 5 6 




1 2 3 4 5 6 
9(ix) Did you feel 
tired? 
1 2 3 4 5 6 
10. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with friends, 
relatives etc.) (Please tick one box.) 
All of the time – 
Most of the time – 
Some of the time – 
A little of the time – 
None of the time –  
11. How TRUE or FALSE is each of the following statements for you? Please circle one 
number on each line 
  
 
Definitely true Mostly 
true 
Don’t know Mostly 
false 
Definitely false 
11(i) I seem 
to get 
sick a 















1 2 3 4 5 




























Appendix B1  
Scoring SF-36 Step 1: Recoding Items 
Item numbers  
Change original 
response category *  
To recoded 
value of: 
1, 2, 20, 22, 34, 36 1 → 100  
 2 → 75 
 3 → 50  
 4 → 25 
 5 → 0 
3, 4, 5, 6, 7, 8, 9, 10, 11, 12  1 → 0  
 2 → 50 
 3 → 100  
13, 14, 15, 16, 17, 18, 19 1 → 0 
 2 → 100  
21, 23, 26, 27, 30  1 → 100 
 2 → 80 
 3 → 60 
 4 → 40 
 5 → 20 
 6 → 0 
24, 25, 28, 29, 31 1 → 0 
 2 → 20 
 3 → 40 
 4 → 60 
 5 → 80 
 6 → 100 
32, 33, 35  1 → 0 
 2 → 25 
 3 → 50 
 4 → 75 











Step 2: Averaging Items to Form Scales 
Scale Number of items 
After recoding per Table 1,  
average the following items 
Physical functioning  10 3 4 5 6 7 8 9 10 11 12 
Role limitations due to 
physical health  
4 13 14 15 16 
Role limitations due to 
emotional problems 
3 17 18 19 
Energy/fatigue 4 23 27 29 31 
Emotional well-being 5 24 25 26 28 30 
Social functioning 2 20 32 
Pain 2 21 22 























From: Eleanor Byrne 
Sent: Friday, February 23, 2018 11:14 AM 
To: Marcia Jones George 
Subject: Re: Permission to Use the MS-TAQ for my Research  
Thank you for your interest in the MS-TAQ. It is licensed under Creative Commons Sharealike 
3.0 and is therefore free of charge. You can see all available translations here: 
https://www.openresearchexchange.com/public/library/instruments/26/overview 
I enclose the relevant publication. Please note that the MS-TAQ was developed at a time 
when only injectable drugs were available, so it may require modification to cover newer drugs. 
Please ensure you detail any modifications in your published work. 
If there is anything more I can help you with, please let me know.  
 
Eleanor Byrne 












Appendix C1 (cont’d) 
Multiple Sclerosis Treatment Adherence Questionnaire (MSTAQ)     
Name: _________________________________________________________________     
Today’s date (mm/dd/yyyy): ____________________________________________    
It is important that you take your medication as prescribed by your physician. However, 
from time to time you may find it difficult or impossible to take your DMT as prescribed.  This 
instrument is designed to help you and your physician understand what these barriers are and to 
come up with ways to make it easier to take your treatment.  It is very important that you are 
honest when completing this instrument so that your MS team can help to look after you better.        
     
1) Which of the following are you currently taking to treat Multiple Sclerosis (MS)? (Check 
one)     
Copaxone (Glatiramer Acetate)     
     
     
Avonex or Avonex pre- ‐filled syringe 
(Interferon Beta 1a intramuscular)     
     
Rebif (Interferon Beta 1a subcutaneous)
     
     
Betaseron or Betaferon (Interferon Beta 1b 
subcutaneous)     
     
Tysabri (Natalizumab)     
     
     
Novantrone (Mitoxantrone)     
     
     
Other,  please  specify:     
     
     
I do not know  
Does not apply  





     
2)  On how many days during the last 4 weeks (28) days were you supposed to take this 
medication. (Check one)  
Every day (28 times)     
     
     
Every other day (14 times)           
Three times a week (12 Times          
Once a week (4 times)           
Once a month (1 time)        
Other,  please specify     
     
     
3) During the past 4 weeks (28 days) did you manually inject, use an auto-injection device, or 
do both? (Check one)     
Manual injection only      
     
     
Auto-injection only     
     
     
Both manual and auto-injection 
     
     
Not applicable / I take a pill           
     
4) During the past 4 weeks (28 days), how often was your injection done by someone else? 
(Check one) 
Never          
A few times          
About half the time          
Most of the time          
All or nearly all of the time          





5) Did you miss or forget to take any doses of this medication during the last 4 weeks (28 days)? 
(Check one) 
Yes     
     
     
No     
     
     
     
6) How many doses did you miss or forget?    __________________          
    
 Complete this section only if you missed a dose in the past 28 days       
7) How important were the following factors in missing or forgetting to take a dose? (Please 
check one answer for each).         
     Not important 






     
Extremely 
important
     
Memory problems     
     
0     1     2     3     
Too busy   0     1     2     3     
Side effects of injection   0     1     2     3     
Side effects of medication     
     
0     1     2     3     
Fear of needles 0     1     2     3     
Needing someone to help me 
take my medication    
0     1     2     3     
Ran out of medication or 
could not refill my 
prescription     
0     1     2     3     
Away from home and could 
not access my medication     
     





Feeling anxious, depressed, or 
nervous about taking my 
medication     
     
0     1     2     3     
Dissatisfaction with my    
medication     
     
0     1     2     3     
Did not want my medication 
to interfere with activities    
     
0     1     2     3     
Tired of taking my 
medication     
     
0     1     2     3     
Did not feel like taking my 
medication    
     
0     1     2     3     



















The Brief Religious COPE 
The following items deal with ways you coped with the negative event in your life. There are 
many ways to try to deal with problems. These items ask what you did to cope with this negative 
event. Obviously different people deal with things in different ways‚ but we are interested in how 
you tried to deal with it. Each item says something about a particular way of coping. We want to 
know to what extent you did what the item says. How much or how frequently. Don’t answer on 
the basis of what worked or not - just whether or not you did it. Use these response choices. Try 
to rate each item separately in your mind from the others. Make your answers as true FOR YOU 


























Looked for a stronger connection with God 
    
2 
Sought God’s love and care 
    
3 
Sought help from God in letting go of my anger 
    
4 
Tried to put my plans into action together with God 
    
5 
Tried to see how God might be trying to strengthen 
me in this situation 
    
6 
Asked forgiveness for my sins 
    
7 
Focused on religion to stop worrying about my 
problems 
    
8 
Wondered whether God had abandoned me 
    
9 
Felt punished by God for my lack of devotion 
    
10 
Wondered what I did for God to punish me 
    
11 
Questioned God’s love for me 
    
12 
Wondered whether my church had abandoned me 
    
13 
Decided the devil made this happen 
    
14 
Questioned the power of God 
    











Demographic Data Questionnaire 
1.  Have you been diagnosed with multiple sclerosis by a health care provider? 
Yes _____       
No_____ 
 
2.  What type of multiple sclerosis do you have? 
Relapsing Multiple Sclerosis ________      
Progressive Multiple Sclerosis _____ 
 
3.  What is your gender identity? 
Male _____    
Female _____ 
Other _____ 





Latter Day Saints or Mormon  
Buddhist  
Hindu  
Agnostic (you are not sure if there is a God.)  
Atheist (you believe there is no God.)  
Spiritual, but not committed to a particular faith 
Other _______ 
5.  Which category below includes your age? 
18-24 years-old _____      
25-34 years-old _____      
35-44 years-old _____       
45-54 years-old _____      
55 to 64 years-old _____      
65 to 74 years-old _____ 
75 years or older ______ 
 
6.  What is your CURRENT marital status? (CHOOSE ONLY ONE) 
Single _____      
Married ______ 
Domestic partnership _____      
Separated _____      






7.  What is the highest level of education you have completed or the highest degree 
you have received? 
Some high school, no diploma _____      
High School graduate, diploma or equivalent _____   
Some college credit, no degree _____ 
Trade/technical/vocational training _____ 
Associate degree _____      
Bachelor’s degree _____     
Master’s degree _____   
Professional degree _____ 
Doctoral degree _____ 
8.  Which of the following categories best describe your employment status? 
(CHOOSE ONLY ONE) 
Employed fulltime _____      
Employed part-time _____       
Retired ______    
Not employed _____ 
Unable to work ______ 
 
9.  How much total combined income did ALL members of you household earn in 
2018? 
Less than $20,000 _____        
$20,000 to $34,000 _____      
$35,000 to $49,000_____ 
$50,000 to $74,000_____      
$75,000 to $99,000 _____             
Over $100,000 _____ 
 
10.  How would you describe yourself? 
White _____      
Hispanic, Latino or Spanish origin _____     
Black or African American _____ 
Native American or American Indian _____ 


























From: Tyry, Tuula - SJHMC 
Sent: Monday, April 17, 2017 2:36 PM 
To: Marcia Jones George 
Subject: RE: Researcher Information Form submission 
 
 
Hi Marcia – the EC approved your proposal but would like to get further information on 
the basis of the power calculation once you have figured out the methodology in more detail. In 
other words, we would like to make sure that you get enough responses for a meaningful 
analysis. Please keep us in the loop in terms of the instruments you will be using, and we will 




On Feb 22, 2019, at 6:35 PM, Tyry, Tuula - SJHMC <Tuula.Tyry@dignityhealth.org>  
Your proposal resubmission has been approved : )  Let me know when you are ready to discuss 
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Protection of Survey Participants 
This survey was designed to be completely anonymous to protect the participants.  
No identifying information, such as state or zip code, will be asked in this survey.  Use of the 
blind “cc” feature when sending emails to participants and the procedure for gaining consent 
further protects the participant anonymity.   
Procedure for consent: The participant may only access the survey by clicking on the survey link, 
and then the participant may read the consent and then click on the continue button, as tacit 
consent (with no signature) protects the anonymity of the participant.   Additionally, 
SurveyMonkey provides for the protection of survey participants and data in the following 
safeguards and procedures:   
Physical Security: 
SurveyMonkey’s information systems and technical infrastructure are hosted within SOC 2 
accredited data centers. Physical security controls at our data centers include 24x7 monitoring, 
cameras, visitor logs, entry requirements, and dedicated cages for SurveyMonkey hardware. 
Access Control 
Access to SurveyMonkey’s technology resources is only permitted through secure connectivity 
(e.g., VPN, SSH) and requires multi-factor authentication. Password policy requires complexity, 
expiration, and lockout and disallows reuse. SurveyMonkey grants access on a need to know 
based on least privilege rules, reviews permissions quarterly, and revokes access immediately 







SurveyMonkey maintains and regularly reviews and updates its information security policies, at 
least on an annual basis. Employees must acknowledge policies on an annual basis and undergo 
additional training such as HIPAA training, Secure Coding, PCI, and job-specific security and 
skills development and privacy law training for crucial job functions. The training schedule is 
designed to adhere to all specifications and regulations applicable to SurveyMonkey. 
Personnel: 
SurveyMonkey conducts background screening at the time of hire (to the extent permitted or 
facilitated by applicable laws and countries). SurveyMonkey also communicates its information 
security policies to all personnel (who must acknowledge this) and requires new employees to 
sign non-disclosure agreements and provides ongoing privacy and security training. 
Dedicated Security Personnel: 
SurveyMonkey also has a dedicated Trust & Security organization, which focuses on application, 
network, and system security. This team is also responsible for security compliance, education, 
and incident response. 
Vulnerability Management and Penetration Tests: 
SurveyMonkey maintains a documented vulnerability management program which includes 
periodic scans, identification, and remediation of security vulnerabilities on servers, 
workstations, network equipment, and applications. All networks, including test and production 
environments, are regularly scanned using trusted third-party vendors. Critical patches are 
applied to servers on a priority basis and as appropriate for all other patches.  Regular internal 







Data in transit is encrypted using secure TLS cryptographic protocols. SurveyMonkey data is 
also encrypted at rest. 
Development: 
SurveyMonkey employs secure coding techniques and best practices, focused around the 
OWASP Top Ten. Developers are formally trained in secure web application development 
practices upon hire and annually.  Development, testing, and production environments are 
separated. All changes are peer-reviewed and logged for performance, audit, and forensic 
purposes before deployment into the production environment. 
Asset Management: 
SurveyMonkey maintains an asset management policy which includes identification, 
classification, retention, and disposal of information and assets. Company-issued devices are 
equipped with full hard disk encryption and up-to-date antivirus software. Only company-issued 
devices are permitted to access corporate and production networks. 
Information Security Incident Management: 
SurveyMonkey maintains security incident response policies and procedures covering the initial 
response, investigation, customer notification (no less than as required by applicable law), public 
communication, and remediation. These policies are reviewed regularly and tested bi-annually. 
Breach Notification: 
Despite best efforts, no method of transmission over the Internet and no method of electronic 
storage is entirely secure. If SurveyMonkey learns of a security breach, affected users are 
notified so that they can take appropriate protective steps. Breach notification procedures are 





applicable industry rules or standards. Customers are provided with all information necessary for 
them to meet regulatory reporting obligations. 
Information Security Aspects of Business Continuity Management: 
SurveyMonkey’s databases are backed up on a rotating basis of full and incremental backups and 
verified regularly. Backups are encrypted and stored within the production environment to 
preserve their confidentiality and integrity and are tested regularly to ensure availability. 
Logging and Monitoring 
Application and infrastructure systems log information to a centrally managed log repository for 
troubleshooting, security reviews, and analysis by authorized SurveyMonkey personnel. Logs are 
preserved by regulatory requirements. Customers are provided with reasonable assistance and 







Factor Analysis of the Brief RCOPE in People With Multiple Sclerosis 
This analysis aimed to explore the factors of the Brief RCOPE in a cross-sectional survey 
among people with MS (N = 277) to test Pargament's (1997) Theory of Religious Coping.  The 
study aimed to examine the relations between Perceived health status, Adherence to Disease 
Modifying Treatment, and Religious Coping. Coping refers to the way people manage stressors 
in their lives.  Religious Coping is one way people use religion to deal with difficulties in their 
lives.  The Brief-RCOPE scale was formed based on Pargament's (1997) theory and measures 
religious coping (see Appendix E).   
The scale's items were developed through interviews with people experiencing negative 
events in their lives. Pargament’s sample was primarily white (93%) and female (69%), similar 
to this study's sample (see Table 2).  However, unlike this study's sample, Pargament's sample 
were college freshmen (70%) with an average age of 19 years (range: 18 – 38 years).  Criteria 
for selecting the items were based on factor-loading, the need to represent various coping 
methods, and the need for a brief measure of religious coping (Pargament et al., 2000). 
Confirmatory factor analysis (CFA) of the 14 items from the two subscales demonstrated 
significant results ( 2 = 210.77, df = 64, p < .001) among the 540 college students (K. I. 
Pargament et al., 2000).  When chi-squares are statistically significant, additional fit indices can 
provide a better indication of fit (Tabachnick & Fidell, 2018).  Pargament et al. (2000) 
acknowledged needing additional fit measures due to the significant chi-square results. 
Subsequently, two other fit indices were calculated. Chi-square to the degree of freedom ratio 





error of approximation was calculated as 0.46, which is less than .05 indicating an acceptable fit 
(Browne et al., 2002).   
The current analysis aims to evaluate the two-factor structure outlined by Pargament et al. 
(2000). The Brief RCOPE consists of 14 items that measure positive and negative religious 
coping. The data were analyzed using PCA with oblimin rotation to determine validity. Oblimin 
rotation is best used for dimensions that are correlated, as found in this study. For this study, PRC 
and NRC were correlated (r = .17), with Cronbach's alpha PRC (.96) and NRC (.84). 
The adequacy of FA was examined through Kaiser-Meyer-Olkin (KMO) and Bartlett's 
test of sphericity. Kaiser-Meyer-Olkin's (KMO) measure of sampling adequacy denotes an 
adequate sample size, indicating partial correlations are small and robust factors may emerge 
(Tabachnick & Fidell, 2018). Sample sizes above 200 are desired with recommended KMO 
values above .6 (Tabachnick & Fidell, 2018). The rotated KMO factor extracted is higher (.875) 
than 0.6 signifying sufficient items for each. The variables chosen are related to each other: 
Bartlett's test of sphericity was significant (2 =2883, df =91, p <. 001), indicating they are 
adequately related for factor analysis. To determine the relationship between variables and 
achieve definitions of the factors, items with factor loadings correlations equal to or above .30 
are desired (see Table 17). Factor loadings lower than .30 are considered random factors.    
The analyses to estimate the number of factors, multicollinearity, and correlation matrices 
suggest a two-factor solution (Eigenvalue over 1) as shown on the scree plot (see Figure 5) 








Figure 5  
Brief RCOPE Eigenvalues  
 
There are high correlations among the first seven variables, PRC, with the lowest (r = .6) 
and the highest (r = .8) indicating the items are sufficiently related.  Variables 8 – 14, NRC, 













Table 17  
































































































































































































































































































































































































































- .89 .76 .83 .81 .76 .77 .19 .18 .04 .05 .22 .17 -.04 
Sought Gods 
love and care 
 
.89 - .73 .86 .86 .75 .74 .11 .15 .05 .04 .18 .15 -.07 
Sought help 
from God in 
letting go of 
my anger 

































































































































































































































































































































































































































Tried to put 




.83 .86 .75 - .87 .75 .76 .08 .12 -.00 .04 .22 .17 -.04 





me in this 
situation 
 
.81 .86 .76 .87 - .71 .77 .08 .12 -.00 .04 .22 .17 -.04 
Asked 
forgiveness 
for my sins 
 















































































































































































































































































































































































































































.11 .11 .18 .08 .08 .11 .07 - .54 .45 .52 .41 .36 .39 
Felt punished 
by God for 
my lack of 
devotion 
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.17 .15 .16 .17 .17 .13 .19 .36 .58 .32 .30 .42 - .27 
Questioned 
the power of 
God 





The analysis yielded two factors explaining 67.40% of the variance for the entire set of 
14 variables (see Table 18). The first factor explained 42.72%, and the second factor explained 
24.78% of the variance. Pargament labeled the first factor Positive Religious Coping and 
included questions numbered 1 - 7. The second factor labeled Negative Religious Coping 
includes questions 8 – 14. There is a correlation (r = .14) between PRC and NRC (see Table 19) 
to make them sufficiently related (determinant = 8.72) but identifies each as a separate construct.  
Table 18  
Principal component Analysis for 14-items Brief-RCOPE 
Factor Eigenvalue Percent of Variance Cumulative Percent 
1 5.98 42.73 42.73 
2 3.46 24.78 67.51 
3 .927 6.62 74.13 
4 .825 5.89 80.02 
5 .569 4.06 84.09 
6 .530 3.78 87.87 
7 .356 2.54 90.42 
8 .316 2.25 92.68 
9 .247 1.76 94.44 
10 .225 1.60 96.04 
11 .190 1.35 97.40 
12 .167 1.19 98.59 
13 .119 .84 99.44 
14 .077 .55 100 









Table 19  
Between Factor Correlation Matrix Brief-RCOPE  
Component PRC NRC 
PRC 1.000 .14 
NRC .14 1.000 
 
The pattern matrix (see Table 20) shows two distinct components. The first seven 
variables load tightly together in the first component. This component is a measure of PRC. The 
second component, variables 8 – 14, is also tightly loaded together and is an NRC measure.  
Communality scores for each variable indicate the scale is better at measuring PRC. Values close 
to 1 are preferable (Tabachnick & Fidell, 2018). Notably, variables 1 thru 7 account for 72% to 
86% of the Religious Coping variance.  However, variables loaded lower on factor 2 and 















Table 20  
Communalities Brief RCOPE  
 Variable Component Communalities 
  1 2  
1 
 
Looked for a stronger 
connection with God. 
 
.92 .00 .86 
2 Sought Gods love and 
care 
.93 -.02 .86 
3 Sought help from God in 
letting go of my anger. 
 
.84 .07 .74 
4 Tried to put my plans 
into action together with 
God. 
 
.93 -.03 .86 
5 Tried to see how God 
might be trying to 
strengthen me in this 
situation. 
 
.92 -.03 .84 
6 Asked forgiveness for 
my sins. 
 
.84 .03 .72 
7 Focused on religion to 
stop worrying about my 
problems. 
 
.87 -.01 .77 
8 Wondered whether God 
has abandoned me. 
 
.01 .73 .54 
9 Felt punished by God for 
my lack of devotion. 
 
.06 .82 .70 
10 Wondered what I did for 
God to punish me. 
 
-.06 .78 .60 
11 Questioned God's love 
for me. 
 





 Variable Component Communalities 
12 Wondered whether my 
church has abandoned 
me. 
 
.19 .59 .42 
13 Decided the devil made 
this happen. 
 
.12 .59 .39 
14 Questioned the power of 
God 
-.17 .64 .42 
Note. Extraction Method: Principal Component Analysis 
Three variables: wondered whether my church has abandoned me (.42), decided the devil 
made this happen (.39), and questioned the power of God (.42) in component two, each 
contributed less than 50% to the model. Subsequently, those three variables could be a separate 
indicator of Religious Coping. Paika et al. (2017) also found low scores on the mentioned 
variables in their analysis of the Brief-RCOPE.   
For this study, participants reported using both PRC and NRC to cope with life 
stressors similarly. Scores ranged from 6 to 24 for PRC and 7 to 21 for NRC. Pargament agrees 
that study participants used more PRC than NRC (Pargament et al., 2000); however, NRC was 
more predictive of adjustment and mental health. Studies using the Brief-RCOPE 
(Mohammadzadeh & Najafi, 2016; Paika et al., 2017) report Cronbach's alpha > .80.  
Mohammadzadeh and Najafi (2016) explored the scale's factor structure with PCA on an 
Iranian sample.They found two distinct factors explaining 52.2% of observed variance, which 
is lower than the results obtained for this analysis.  
This study was the first to use Brief RCOPE for patients with MS. It was reasoned that 
people would generally turn to religion to cope with chronic disease as a stressor. The MCS was 





with PRC and the study variables. What is unclear is the degree of religious coping people use 
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